Tenet Healthcare Corporation(NYSE:THC) 
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy se...
Website: http://www.tenethealth.com
Founded: 1969
Full Time Employees: 110,000
Sector: Healthcare
Industry: Medical Care Facilities
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-09-30 | 2006-03-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-09-30 | 2004-06-30 | 2003-09-30 | 2003-06-30 | 2003-02-28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net operating revenues | 5,368,000,000 | 5,527,000,000 | 5,289,000,000 | 5,271,000,000 | 5,223,000,000 | 5,072,000,000 | 5,122,000,000 | 5,103,000,000 | 5,368,000,000 | 5,379,000,000 | 5,066,000,000 | 5,082,000,000 | 5,021,000,000 | 4,990,000,000 | 4,801,000,000 | 4,638,000,000 | 4,745,000,000 | 4,856,000,000 | 4,894,000,000 | 4,954,000,000 | 4,781,000,000 | 4,915,000,000 | 4,557,000,000 | 3,648,000,000 | 4,520,000,000 | 4,806,000,000 | 4,568,000,000 | 4,560,000,000 | 4,545,000,000 | 4,619,000,000 | 4,489,000,000 | 4,506,000,000 | 4,699,000,000 | 4,978,000,000 | 4,586,000,000 | 4,802,000,000 | 4,813,000,000 | 19,606,239,000 | 4,849,000 | 4,868,000 | 5,044,000,000 | -13,589,366,000 | 4,692,000,000 | 4,492,000,000 | 4,428,000 | -12,130,385,000 | 4,179,000,000 | 4,042,000,000 | 3,926,000,000 | -7,205,898,000 | 2,408,000,000 | 2,422,000,000 | 2,387,000,000 | -6,778,881,000 | 2,221,000,000 | 2,265,000,000 | 2,350,000,000 | -7,213,146,000 | 2,342,000,000 | 2,374,000,000 | 2,506,000 | 2,301,000 | 2,262,000 | 2,303,000 | 2,339,000 | 2,261,000 | 2,262,000 | 2,229,000 | 2,279,000 | 8,656,532,000 | 2,158,000 | 2,184,000 | 2,371,000 | 2,251,000,000 | 2,212,000,000 | 2,228,000,000 | 2,279,000,000 | 2,117,000 | 2,414,000 | 2,387,000 | 2,421,000 | 2,499,000 | 2,440,000 | 2,570,000 | 3,297,000 | 3,379,000 | 3,686,000,000 |
revenue from contract termination | 413,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in earnings of unconsolidated affiliates | 51,000,000 | 83,000,000 | 64,000,000 | 61,000,000 | 56,000,000 | 78,000,000 | 62,000,000 | 61,000,000 | 59,000,000 | 73,000,000 | 51,000,000 | 54,000,000 | 50,000,000 | 65,000,000 | 51,000,000 | 54,000,000 | 46,000,000 | 77,000,000 | 45,000,000 | 54,000,000 | 42,000,000 | 66,000,000 | 44,000,000 | 31,000,000 | 28,000,000 | 61,000,000 | 38,000,000 | 42,000,000 | 34,000,000 | 53,000,000 | 33,000,000 | 39,000,000 | 25,000,000 | 49,000,000 | 38,000,000 | 28,000,000 | 29,000,000 | 130,915,000 | 31,000 | 30,000 | 24,000,000 | -47,901,000 | 28,000,000 | 16,000,000 | |||||||||||||||||||||||||||||||||||||||||||
operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
salaries, wages and benefits | 2,174,000,000 | 2,222,000,000 | 2,204,000,000 | 2,160,000,000 | 2,119,000,000 | 2,094,000,000 | 2,218,000,000 | 2,168,000,000 | 2,321,000,000 | 2,315,000,000 | 2,288,000,000 | 2,285,000,000 | 2,258,000,000 | 2,306,000,000 | 2,230,000,000 | 2,126,000,000 | 2,182,000,000 | 2,188,000,000 | 2,209,000,000 | 2,280,000,000 | 2,201,000,000 | 2,225,000,000 | 2,142,000,000 | 1,864,000,000 | 2,187,000,000 | 2,229,000,000 | 2,174,000,000 | 2,148,000,000 | 2,153,000,000 | 2,156,000,000 | 2,116,000,000 | 2,135,000,000 | 2,227,000,000 | 2,284,000,000 | 2,264,000,000 | 2,346,000,000 | 2,380,000,000 | 9,348,968,000 | 2,314,000 | 2,316,000 | 2,402,000,000 | -6,558,989,000 | 2,258,000,000 | 2,185,000,000 | 2,125,000 | -5,896,977,000 | 2,028,000,000 | 1,956,000,000 | 1,921,000,000 | -3,493,629,000 | 1,172,000,000 | 1,166,000,000 | 1,161,000,000 | -3,161,743,000 | 1,050,000,000 | 1,054,000,000 | 1,078,000,000 | -3,048,918,000 | 1,019,000,000 | 999,000,000 | 1,035,000 | 967,000 | 977,000 | 969,000 | 987,000 | 989,000 | 954,000 | 949,000 | 975,000 | 3,813,151,000 | 952,000 | 967,000 | 1,036,000 | 1,023,000,000 | 983,000,000 | 993,000,000 | 1,019,000,000 | 953,000 | 1,075,000 | 1,099,000 | 1,114,000 | ||||||
supplies | 961,000,000 | 1,010,000,000 | 931,000,000 | 932,000,000 | 907,000,000 | 930,000,000 | 881,000,000 | 908,000,000 | 928,000,000 | 931,000,000 | 877,000,000 | 891,000,000 | 891,000,000 | 860,000,000 | 817,000,000 | 811,000,000 | 785,000,000 | 838,000,000 | 827,000,000 | 859,000,000 | 804,000,000 | 824,000,000 | 784,000,000 | 611,000,000 | 763,000,000 | 803,000,000 | 760,000,000 | 753,000,000 | 741,000,000 | 756,000,000 | 726,000,000 | 748,000,000 | 774,000,000 | 800,000,000 | 740,000,000 | 780,000,000 | 765,000,000 | 3,121,649,000 | 767,000 | 773,000 | 811,000,000 | -2,143,037,000 | 752,000,000 | 707,000,000 | 687,000 | -1,939,370,000 | 665,000,000 | 649,000,000 | 628,000,000 | -1,156,216,000 | 387,000,000 | 387,000,000 | 384,000,000 | -1,162,448,000 | 376,000,000 | 389,000,000 | 406,000,000 | -1,189,418,000 | 388,000,000 | 399,000,000 | 404,000 | 394,000 | 390,000 | 395,000 | 398,000 | 394,000 | 389,000 | 395,000 | 395,000 | 1,526,860,000 | 380,000 | 392,000 | 420,000 | 406,000,000 | 383,000,000 | 399,000,000 | 408,000,000 | 386,000 | 449,000 | 446,000 | 447,000 | 457,000 | 423,000 | 437,000 | 521,000 | 525,000 | 558,000,000 |
other operating expenses | 1,122,000,000 | 1,195,000,000 | 1,119,000,000 | 1,119,000,000 | 1,090,000,000 | 1,079,000,000 | 1,111,000,000 | 1,148,000,000 | 1,154,000,000 | 1,196,000,000 | 1,101,000,000 | 1,125,000,000 | 1,093,000,000 | 1,032,000,000 | 1,018,000,000 | 1,006,000,000 | 942,000,000 | 1,029,000,000 | 1,051,000,000 | 1,054,000,000 | 1,072,000,000 | 1,071,000,000 | 1,058,000,000 | 983,000,000 | 1,013,000,000 | 1,029,000,000 | 1,042,000,000 | 1,044,000,000 | 1,074,000,000 | 1,078,000,000 | 1,094,000,000 | 1,027,000,000 | 1,060,000,000 | 1,104,000,000 | 1,120,000,000 | 1,159,000,000 | 1,187,000,000 | 4,887,314,000 | 1,231,000 | 1,213,000 | 1,242,000,000 | -3,320,445,000 | 1,151,000,000 | 1,081,000,000 | 1,093,000 | -3,061,886,000 | 1,032,000,000 | 1,035,000,000 | 999,000,000 | -1,707,299,000 | 575,000,000 | 567,000,000 | 568,000,000 | -1,601,853,000 | 539,000,000 | 534,000,000 | 553,000,000 | -1,578,900,000 | 547,000,000 | 528,000,000 | 506,000 | 468,000 | 505,000 | 498,000 | 467,000 | 479,000 | 486,000 | 472,000 | 477,000 | 1,953,520,000 | 504,000 | 508,000 | 532,000 | 522,000,000 | 510,000,000 | 529,000,000 | 522,000,000 | 513,000 | 536,000 | 554,000 | 539,000 | 534,000 | 557,000 | 610,000 | 754,000 | 753,000 | 858,000,000 |
depreciation and amortization | 229,000,000 | 231,000,000 | 218,000,000 | 208,000,000 | 206,000,000 | 193,000,000 | 209,000,000 | 208,000,000 | 208,000,000 | 216,000,000 | 224,000,000 | 213,000,000 | 217,000,000 | 213,000,000 | 209,000,000 | 216,000,000 | 203,000,000 | 201,000,000 | 209,000,000 | 221,000,000 | 224,000,000 | 233,000,000 | 215,000,000 | 206,000,000 | 203,000,000 | 223,000,000 | 205,000,000 | 214,000,000 | 208,000,000 | 200,000,000 | 204,000,000 | 194,000,000 | 204,000,000 | 208,000,000 | 219,000,000 | 222,000,000 | 221,000,000 | 849,368,000 | 205,000 | 215,000 | 212,000,000 | -588,203,000 | 185,000,000 | 197,000,000 | 207,000 | -608,151,000 | 207,000,000 | 209,000,000 | 193,000,000 | -353,455,000 | 119,000,000 | 121,000,000 | 114,000,000 | -313,570,000 | 110,000,000 | 104,000,000 | 104,000,000 | -307,587,000 | 103,000,000 | 104,000,000 | 101,000 | 101,000 | 101,000 | 97,000 | 95,000 | 95,000 | 97,000 | 98,000 | 97,000 | 372,723,000 | 94,000 | 95,000 | 95,000 | ||||||||||||||
impairment and restructuring charges, and acquisition-related costs | 24,000,000 | 64,000,000 | 23,000,000 | 24,000,000 | 19,000,000 | 27,000,000 | 19,000,000 | 29,000,000 | 27,000,000 | 53,000,000 | 47,000,000 | 16,000,000 | 21,000,000 | 129,000,000 | 24,000,000 | 57,000,000 | 16,000,000 | 30,000,000 | 15,000,000 | 20,000,000 | 20,000,000 | 124,000,000 | 57,000,000 | 54,000,000 | 55,000,000 | 84,000,000 | 46,000,000 | 36,000,000 | 19,000,000 | 86,000,000 | 46,000,000 | 30,000,000 | 47,000,000 | 138,000,000 | 329,000,000 | 41,000,000 | 33,000,000 | 201,919,000 | 31,000 | 22,000 | 28,000,000 | -265,682,000 | 44,000,000 | 193,000,000 | 29,000 | -89,847,000 | 37,000,000 | 32,000,000 | 21,000,000 | -44,897,000 | 20,000,000 | 11,000,000 | 14,000,000 | ||||||||||||||||||||||||||||||||||
litigation and investigation costs | 27,000,000 | 30,000,000 | -11,000,000 | 28,000,000 | 17,000,000 | 17,000,000 | 9,000,000 | 5,000,000 | 4,000,000 | 19,000,000 | 14,000,000 | 10,000,000 | 4,000,000 | 20,000,000 | 12,000,000 | 18,000,000 | 20,000,000 | 52,000,000 | 29,000,000 | 22,000,000 | 13,000,000 | 31,000,000 | 9,000,000 | 2,000,000 | 2,000,000 | 26,000,000 | 84,000,000 | 18,000,000 | 13,000,000 | 10,000,000 | 9,000,000 | 13,000,000 | 6,000,000 | 11,000,000 | 6,000,000 | 1,000,000 | 5,000,000 | 72,750 | 4,000 | 114,000 | 173,000,000 | -66,709,000 | 50,000,000 | 14,000,000 | 3,000 | -18,975,000 | 4,000,000 | 12,000,000 | 3,000,000 | -2,969,000 | 1,000,000 | 2,000,000 | -2,995,000 | 1,000,000 | 2,000,000 | 6,000,000 | 5,000,000 | 8,000,000 | 11,000 | 1,500 | 2,000 | 2,000 | 2,000 | 9,000 | 1,000 | 40,955,000 | -5,000 | 3,000 | 47,000 | 12,000,000 | 3,000,000 | ||||||||||||||||
net gains on sales, consolidation and deconsolidation of facilities | -1,000,000 | -1,000,000 | -20,000,000 | -22,000,000 | -58,000,000 | -2,500,000,000 | -1,000,000 | -106,750,000 | -412,000,000 | -15,000,000 | -8,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating income | 1,296,000,000 | 853,000,000 | 889,000,000 | 823,000,000 | 943,000,000 | 821,000,000 | 1,089,000,000 | 761,000,000 | 3,285,000,000 | 735,000,000 | 568,000,000 | 604,000,000 | 603,000,000 | 536,000,000 | 596,000,000 | 553,000,000 | 648,000,000 | 751,000,000 | 1,014,000,000 | 586,000,000 | 520,000,000 | 920,000,000 | 271,000,000 | 471,000,000 | 327,000,000 | 460,000,000 | 294,000,000 | 388,000,000 | 371,000,000 | 404,000,000 | 320,000,000 | 406,000,000 | 517,000,000 | 485,000,000 | 51,000,000 | 310,000,000 | 267,000,000 | 1,218,053,000 | 333,000 | 267,000 | 347,000,000 | -739,944,000 | 287,000,000 | 164,000,000 | 290,000 | -587,075,000 | 211,000,000 | 207,000,000 | 170,000,000 | -495,337,000 | 148,000,000 | 202,000,000 | 146,000,000 | -537,251,000 | 153,000,000 | 180,000,000 | 205,000,000 | -500,350,000 | 79,000,000 | 163,000,000 | 259,000 | 165,000 | 97,000 | 171,000 | 201,000 | 91,000 | 133,000 | 138,000 | 173,000 | 299,793,000 | 66,000 | 63,000 | 91,000 | 28,000,000 | 70,000,000 | 58,000,000 | 98,000,000 | 21,000 | 104,000 | 69,000 | 98,000 | 18,000 | |||||
yoy | 37.43% | 3.90% | -18.37% | 8.15% | -71.29% | 11.70% | 91.73% | 25.99% | 444.78% | 37.13% | -4.70% | 9.22% | -6.94% | -28.63% | -41.22% | -5.63% | 24.62% | -18.37% | 274.17% | 24.42% | 59.02% | 100.00% | -7.82% | 21.39% | -11.86% | 13.86% | -8.13% | -4.43% | -28.24% | -16.70% | 527.45% | 30.97% | 93.63% | -60.18% | 15215.32% | 116004.87% | -23.05% | -264.61% | -99.88% | -99.84% | 119555.17% | 26.04% | 36.02% | -20.77% | -99.83% | 18.52% | 42.57% | 2.48% | 16.44% | -7.80% | -3.27% | 12.22% | -28.78% | 7.38% | 93.67% | 10.43% | 79050.58% | -303342.42% | 81343.30% | 95221.64% | 28.86% | 81.32% | -27.07% | 23.91% | 16.18% | -99.97% | 101.52% | 119.05% | 90.11% | 970.69% | -99.91% | -99.89% | -99.91% | 133233.33% | 67207.69% | 141928.99% | -78.57% | 477.78% | |||||||||
qoq | 51.93% | -4.05% | 8.02% | -12.73% | 14.86% | -24.61% | 43.10% | -76.83% | 346.94% | 29.40% | -5.96% | 0.17% | 12.50% | -10.07% | 7.78% | -14.66% | -13.72% | -25.94% | 73.04% | 12.69% | -43.48% | 239.48% | -42.46% | 44.04% | -28.91% | 56.46% | -24.23% | 4.58% | -8.17% | 26.25% | -21.18% | -21.47% | 6.60% | 850.98% | -83.55% | 16.10% | -78.08% | 365681.68% | 24.72% | -99.92% | -146.90% | -357.82% | 75.00% | 56451.72% | -100.05% | -378.23% | 1.93% | 21.76% | -134.32% | -434.69% | -26.73% | 38.36% | -127.18% | -451.14% | -15.00% | -12.20% | -140.97% | -733.35% | -51.53% | 62834.36% | 56.97% | 70.10% | -43.27% | -14.93% | 120.88% | -31.58% | -3.62% | -20.23% | -99.94% | 454131.82% | 4.76% | -30.77% | -99.67% | -60.00% | 20.69% | -40.82% | 466566.67% | -79.81% | -29.59% | 444.44% | |||||||
interest expense | -205,000,000 | -205,000,000 | -206,000,000 | -206,000,000 | -204,000,000 | -203,000,000 | -202,000,000 | -203,000,000 | -218,000,000 | -227,000,000 | -227,000,000 | -226,000,000 | -221,000,000 | -219,000,000 | -222,000,000 | -222,000,000 | -227,000,000 | -221,000,000 | -227,000,000 | -235,000,000 | -240,000,000 | -242,000,000 | -263,000,000 | -255,000,000 | -243,000,000 | -243,000,000 | -244,000,000 | -247,000,000 | -251,000,000 | -246,000,000 | -249,000,000 | -254,000,000 | -255,000,000 | -253,000,000 | -257,000,000 | -260,000,000 | -258,000,000 | -978,270,000 | -243,000 | -244,000 | -243,000,000 | 663,088,000 | -248,000,000 | -217,000,000 | -199,000 | 557,246,000 | -186,000,000 | -68,750,000 | -59,000,000 | -98,000,000 | -118,000 | -101,000 | -107,000 | -107,000 | -109,000 | -103,000 | -112,000 | -120,000 | -110,000 | -417,688,000 | -106,000 | -102,000 | -104,000 | ||||||||||||||||||||||||
other non-operating income | 41,000,000 | 37,000,000 | 29,000,000 | 25,000,000 | 26,000,000 | 37,000,000 | 35,000,000 | 29,000,000 | 25,000,000 | 11,000,000 | 4,000,000 | 6,000,000 | 4,000,000 | 6,000,000 | -2,000,000 | 7,000,000 | -1,000,000 | 10,000,000 | -2,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before income taxes | 1,132,000,000 | 681,000,000 | 712,000,000 | 642,000,000 | 765,000,000 | 655,000,000 | 922,000,000 | 587,000,000 | 3,084,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax expense | -226,000,000 | -37,000,000 | -133,000,000 | -120,000,000 | -143,000,000 | -83,000,000 | -241,000,000 | -110,000,000 | -750,000,000 | -63,000,000 | -79,000,000 | -80,000,000 | -84,000,000 | -74,250,000 | -112,000,000 | -86,000,000 | -99,000,000 | -86,000,000 | -20,000,000 | -30,000,000 | -17,000,000 | -15,250 | -10,000 | -67,000,000 | -18,000,000 | -51,000 | -20,000 | -3,000 | -5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | 906,000,000 | 644,000,000 | 579,000,000 | 522,000,000 | 622,000,000 | 572,000,000 | 681,000,000 | 477,000,000 | 2,334,000,000 | 456,000,000 | 266,000,000 | 293,000,000 | 296,000,000 | 274,000,000 | 268,000,000 | 179,000,000 | 280,000,000 | 419,000,000 | 578,000,000 | 257,000,000 | 222,000,000 | 546,000,000 | -106,000,000 | 169,000,000 | 159,000,000 | 129,000,000 | -152,000,000 | 112,000,000 | 65,000,000 | 102,000,000 | 65,000,000 | 108,000,000 | 191,000,000 | -99,000,000 | -289,000,000 | 32,000,000 | 36,000,000 | 38,250 | 80,000 | 39,000 | 34,000,000 | -75,922,000 | 28,000,000 | -28,000,000 | 76,000 | 18,000,000 | 36,000,000 | -78,867,000 | 32,000,000 | 67,000,000 | 40,000,000 | 15,000,000 | 63,000,000 | 82,000 | 82,000 | 940,000 | 35,000 | 95,000 | 29,000 | -1,000 | -14,000 | 183,000 | 14,500 | 104,000 | -15,000 | -31,000 | -75,000,000 | -59,000,000 | -30,000,000 | 75,000,000 | -89,000 | 70,000 | -408,000 | -21,000 | -3,000 | -308,000 | -195,000 | -55,000,000 | |||||||||
yoy | 45.66% | 12.59% | -14.98% | 9.43% | -73.35% | 25.44% | 156.02% | 62.80% | 688.51% | 66.42% | -0.75% | 63.69% | 5.71% | -34.61% | -53.63% | -30.35% | 26.13% | -23.26% | -645.28% | 52.07% | 39.62% | 323.26% | -30.26% | 50.89% | 144.62% | 26.47% | -333.85% | 3.70% | -65.97% | -203.03% | -122.49% | 237.50% | 430.56% | -258923.53% | -361350.00% | 81951.28% | 5.88% | -100.05% | -99.71% | -100.14% | 44636.84% | 55.56% | -50.00% | 12.50% | -297.17% | 113.33% | 81607.32% | 48680.49% | 1495.74% | 179900.00% | -13.68% | 182.76% | -94100.00% | -350.00% | -48.09% | 100.00% | -100.96% | -6.67% | -690.32% | -100.02% | -100.18% | -99.95% | -100.04% | 84169.66% | -84385.71% | 7252.94% | -357242.86% | 2866.67% | -93.18% | -98.46% | |||||||||||||||||
qoq | 40.68% | 11.23% | 10.92% | -16.08% | 8.74% | -16.01% | 42.77% | -79.56% | 411.84% | 71.43% | -9.22% | -1.01% | 8.03% | 2.24% | 49.72% | -36.07% | -33.17% | -27.51% | 124.90% | 15.77% | -59.34% | -615.09% | -162.72% | 6.29% | 23.26% | -184.87% | -235.71% | 72.31% | -36.27% | 56.92% | -39.81% | -43.46% | -292.93% | -65.74% | -1003.13% | -11.11% | 94017.65% | -52.19% | 105.13% | -99.89% | -144.78% | -371.15% | -200.00% | -36942.11% | -346.46% | 67.50% | 166.67% | -76.19% | 76729.27% | 0.00% | -91.28% | 2585.71% | -63.16% | 227.59% | -3000.00% | -92.86% | -107.65% | 1162.07% | -86.06% | -793.33% | -51.61% | -99.96% | 27.12% | 96.67% | -140.00% | -84369.66% | -227.14% | -117.16% | 1842.86% | 600.00% | 57.95% | -99.65% | |||||||||||||||
less: net income available to noncontrolling interests | 204,000,000 | 273,000,000 | 237,000,000 | 234,000,000 | 216,000,000 | 254,000,000 | 209,000,000 | 218,000,000 | 183,000,000 | 212,000,000 | 165,000,000 | 170,000,000 | 153,000,000 | 172,000,000 | 137,000,000 | 141,000,000 | 140,000,000 | 170,000,000 | 129,000,000 | 138,000,000 | 125,000,000 | 132,000,000 | 90,000,000 | 81,000,000 | 66,000,000 | 127,000,000 | 80,000,000 | 95,000,000 | 84,000,000 | 107,000,000 | 74,000,000 | 82,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income available to tenet healthcare corporation common shareholders | 702,000,000 | 371,000,000 | 342,000,000 | 288,000,000 | 406,000,000 | 318,000,000 | 472,000,000 | 259,000,000 | 2,151,000,000 | 244,000,000 | 101,000,000 | 123,000,000 | 143,000,000 | 102,000,000 | 131,000,000 | 38,000,000 | 140,000,000 | 119,000,000 | 97,000,000 | 88,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings available to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic earnings per share | 8.09 | 4.24 | 3.89 | 3.16 | 4.31 | 3.46 | 4.93 | 2.66 | 21.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share | 8.01 | 4.21 | 3.86 | 3.14 | 4.27 | 3.43 | 4.89 | 2.64 | 21.38 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares and dilutive securities outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 86,801 | 90,150 | 87,951 | 91,135 | 94,242 | 96,904 | 95,665 | 97,267 | 99,581 | 101,639 | 101,544 | 101,766 | 102,289 | 106,929 | 107,923 | 107,790 | 107,483 | 106,833 | 107,050 | 106,822 | 106,309 | 105,010 | 105,263 | 104,794 | 104,353 | 103,398 | 103,558 | 103,198 | 102,788 | 102,110 | 102,402 | 102,147 | 101,392 | 100,592 | 100,812 | 100,612 | 100,000 | 99,523 | 99,341 | 98,768 | 99,167 | 99,537 | 99,244 | 98,699 | 97,801 | 98,036 | 97,677 | 97,161 | 101,648 | 100,894 | 103,010 | 104,103 | 104,200 | 104,244 | 415,011 | 411,373 | 468,753 | 486,794 | 486,902 | 484,321 | 485,210 | 484,610 | 481,917 | 480,240 | 481,008 | 480,447 | 478,372 | 476,898 | 476,308 | 475,066 | 473,405 | 473,984,000,000 | 471,227,000 | 470,069,000 | 469,179,000 | 468,758,000 | 468,047,000 | 466,646,000 | 465,922,000 | 463,629,000 | 465,110,000 | 472,289,000,000 | |||||
diluted | 87,596 | 90,833 | 88,610 | 91,791 | 95,019 | 97,881 | 96,652 | 98,444 | 100,598 | 104,800 | 104,425 | 104,778 | 106,006 | 110,516 | 109,888 | 108,750 | 112,020 | 108,571 | 108,761 | 108,569 | 108,065 | 106,263 | 105,263 | 105,578 | 105,733 | 103,398 | 103,558 | 104,629 | 102,788 | 103,881 | 102,402 | 104,177 | 102,656 | 100,592 | 100,812 | 100,612 | 100,000 | 99,523 | 99,341 | 98,768 | 99,167 | 99,537 | 99,244 | 100,872 | 100,287 | 100,926 | 97,677 | 97,161 | 101,648 | 103,098 | 103,010 | 104,103 | 108,926 | 107,311 | 427,708 | 484,873 | 483,632 | 503,748 | 565,181 | 560,631 | 559,850 | 502,549 | 559,228 | 507,277 | 498,084 | 488,244 | 479,512 | 480,789 | 476,308 | 475,066 | 473,405 | 473,984,000,000 | 471,227,000 | 470,745,000 | 469,179,000 | 468,758,000 | 468,947,000 | 466,646,000 | 465,922,000 | 463,629,000 | 465,110,000 | 472,289,000,000 | |||||
loss from early extinguishment of debt | -8,000,000 | -11,000,000 | -66,000,000 | -43,000,000 | -20,000,000 | -31,000,000 | -23,000,000 | -79,000,000 | -312,000,000 | -4,000,000 | -56,750,000 | -180,000,000 | -47,000,000 | -500,000 | -1,000,000 | -1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net losses on sales, consolidation and deconsolidation of facilities | 38,000,000 | -726,500,000 | -348,000,000 | -3,000,000 | 1,000,000 | -13,000,000 | 1,000,000 | -10,000,000 | -1,000,000 | -1,000,000 | -2,000,000 | 12,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | -27,750,000 | 7,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
grant income | 1,000,000 | 4,000,000 | 5,000,000 | 2,000,000 | 3,000,000 | 8,000,000 | 3,000,000 | 40,000,000 | 54,000,000 | 94,000,000 | 6,000,000 | 138,000,000 | 3,000,000 | 19,000,000 | 31,000,000 | 437,000,000 | -66,000,000 | 511,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share available to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations, before income taxes | 519,000,000 | 345,000,000 | 373,000,000 | 380,000,000 | 321,000,000 | 380,000,000 | 265,000,000 | 378,000,000 | 528,000,000 | 774,000,000 | 319,000,000 | 267,000,000 | 676,000,000 | -304,000,000 | 214,000,000 | 85,000,000 | 215,000,000 | -133,000,000 | 140,000,000 | 74,000,000 | 158,000,000 | 71,000,000 | 150,000,000 | 260,000,000 | 17,000,000 | 57,000,000 | -236,666,000 | 51,000,000 | 78,000,000 | 108,000,000 | -228,839,000 | 21,000,000 | 66,000,000 | 142,000 | 62,000 | -62,000 | 65,000 | 93,000 | -11,000 | 7,000 | 7,000 | 199,000 | 36,947,000 | 110,000 | -35,000 | -9,000 | 1,000,000 | 20,000 | |||||||||||||||||||||||||||||||||||||||
income from continuing operations, before discontinued operations | 456,000,000 | 266,000,000 | 293,000,000 | 296,000,000 | 274,000,000 | 268,000,000 | 179,000,000 | 279,000,000 | 420,000,000 | 577,000,000 | 258,000,000 | 222,000,000 | 546,000,000 | -107,000,000 | 169,000,000 | 160,000,000 | 129,000,000 | -153,000,000 | 110,000,000 | 57,000,000 | 102,000,000 | 65,000,000 | 106,000,000 | 190,000,000 | 9,000,000 | 41,000,000 | -146,791,000 | 33,000,000 | 48,000,000 | 66,000,000 | 39,000,000 | 17,000,000 | 48,000,000 | 91,000 | 60,000 | 940,000 | 45,000 | 90,000 | 24,000 | 4,000 | 3,000 | 194,000 | 18,000 | 114,000 | -19,000 | -10,000 | |||||||||||||||||||||||||||||||||||||||||
income from discontinued operations, net of tax | 1,000,000 | 1,000,000 | 1,000,000 | -1,000,000 | 1,000,000 | 2,000,000 | 8,000,000 | 2,000,000 | 1,000,000 | 3,000,000 | 10,000,000 | 1,000,000 | 1,000,000 | -2,000,000 | 15,000,000 | -9,000 | 22,000 | -10,000 | 5,000 | 6,000 | -5,000 | -17,000 | -11,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts available to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations, net of tax | 244,000,000 | 101,000,000 | 123,000,000 | 143,000,000 | 102,000,000 | 131,000,000 | 38,000,000 | 139,000,000 | 250,000,000 | 448,000,000 | 120,000,000 | 97,000,000 | 88,000,000 | 94,000,000 | 2,000,000 | -233,000,000 | 15,000,000 | -27,000,000 | -5,000,000 | -9,000,000 | 24,000,000 | 98,000,000 | -10,000,000 | 105,877,000 | 33,000,000 | -53,000,000 | -86,000,000 | -128,815,000 | 30,000,000 | 42,000,000 | 57,000,000 | 32,500,000 | 8,000,000 | 40,000,000 | 82,000 | 52,000 | 932,000 | 35,000 | 83,000 | 15,000 | 2,000 | 2,000 | 189,000 | ||||||||||||||||||||||||||||||||||||||||||||
earnings per share available to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
continuing operations | 2.41 | 0.99 | 1.21 | 1.4 | 0.97 | 1.21 | 0.35 | 1.29 | 2.33 | 4.18 | 1.12 | 0.91 | 3.94 | -1.87 | 0.84 | 0.9 | 0.02 | -2.25 | 0.15 | -0.26 | -0.05 | -0.09 | 0.23 | 0.97 | -2.28 | -3.63 | -0.56 | -0.52 | -0.273 | -0.09 | -0.44 | -0.56 | -1.01 | -0.28 | -0.6 | 0.47 | 64,000.27 | 0.1 | -0.11 | -0.28 | -19,970,000 | 8,000,000 | 7,000,000 | -0.83 | 12,998.75 | 0.29 | 0.1 | 0.14 | 0.068 | 0.02 | 0.08 | 0.17 | 0.11 | 1.92 | 0.07 | 0.17 | 0.03 | 0.01 | 0.4 | 0.038 | 0.24 | -0.04 | -0.02 | -80,000.1 | -70,000 | -60,000 | 200,000 | -60 | 30 | -820 | 40 | -500 | -280 | ||||||||||||||
discontinued operations | 0.01 | 0.01 | -0.01 | 0.01 | -0.01 | 0.01 | 0.02 | 0.08 | 0.02 | 0.01 | -0.003 | -0.01 | 0.01 | -0.01 | -0.013 | 0.01 | -0.02 | -0.04 | 0.03 | -0.01 | -0.01 | 0.01 | -0.058 | -0.01 | 0.03 | 0.09 | 0.003 | 0.03 | -0.02 | 0.04 | -0.02 | 0.01 | 0.02 | -0.01 | -0.04 | -0.02 | -0.008 | -0.02 | 0.01 | -0.04 | 120 | ||||||||||||||||||||||||||||||||||||||||||||||
diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from operations | 1,000,000 | 1,000,000 | -1,000,000 | 1,000,000 | -1,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 10,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | -250,000 | -1,000,000 | 2,000,000 | 2,000 | 16,983,000 | 6,000,000 | 1,750,000 | 4,000,000 | 1,000,000 | 1,000,000 | -5,000,000 | -2,000,000 | -3,000,000 | -15,000 | 15,000 | -4,000 | -5,000 | 5,000 | 4,000 | -2,000 | -11,000 | 2,000 | -4,750 | -29,000 | 6,000 | -9,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | 1,000,000 | 1,000,000 | 1,000,000 | -1,000,000 | 1,000,000 | 2,000,000 | 8,000,000 | 2,000,000 | 1,000,000 | 3,000,000 | 1,000,000 | 1,000,000 | -2,000,000 | 15,000,000 | -9,000 | 22,000 | -10,000 | 5,000 | 5,000 | -5,000 | -17,000 | -11,000 | -3,500 | -10,000 | 4,000 | -21,000 | 53,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts available to tenet healthcare corporation common shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other non-operating expense | -2,000,000 | -2,000,000 | -3,000,000 | -1,000,000 | -3,000,000 | -1,000,000 | -1,000,000 | -8,000,000 | -4,000,000 | -5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts available (attributable) to tenet healthcare corporation common shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share available (attributable) to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | -108,000,000 | -197,000,000 | -61,000,000 | -45,000,000 | -130,000,000 | 197,000,000 | -45,000,000 | 75,000,000 | 119,000,000 | -6,000,000 | -44,000,000 | -70,000,000 | 26,250,000 | 60,000,000 | 12,000,000 | 33,000,000 | 16,000 | 1,000,000 | -11,000,000 | 27,000,000 | -16,000 | -11,049,000 | 18,000,000 | 9,000,000 | 1,000,000 | -56,935,000 | 5,000,000 | 20,000,000 | 53,000,000 | -23,975,000 | 29,000,000 | -18,250,000 | -4,000,000 | 18,000,000 | 6,000 | -2,000 | 1,002,000 | 35,000 | -3,000 | -4,000 | 24,981,000 | 4,000 | 16,000 | -1,000 | 4,000,000 | 39,000 | 18,000 | 17,000 | 16,000 | 110,000 | 136,000 | 69,000 | |||||||||||||||||||||||||||||||||||
net income available (loss attributable) to tenet healthcare corporation common shareholders | 249,000,000 | 449,000,000 | 93,000,000 | 2,000,000 | -232,000,000 | 17,000,000 | -19,000,000 | -5,000,000 | -9,000,000 | 26,000,000 | 99,000,000 | -59,000,000 | 42,860,000 | -29,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss from discontinued operations | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss from discontinued operations, net of tax | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss attributable to tenet healthcare corporation common shareholders | -3,750,000 | -196,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss from continuing operations, net of tax | -3,750,000 | -197,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
electronic health record incentives | -250,000 | -1,000,000 | -2,000,000 | -1,000,000 | -1,000,000 | -1,000,000 | -6,000,000 | -31,977,000 | -21,000 | 45,928,000 | -33,000,000 | 71,896,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net operating revenues: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net operating revenues before provision for doubtful accounts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: provision for doubtful accounts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gains on sales, consolidation and deconsolidation of facilities | -110,000,000 | -2,000,000 | -104,000,000 | -23,000,000 | -15,000,000 | -150,849,000 | -147,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: net income attributable to noncontrolling interests | 92,000,000 | 130,000,000 | 78,000,000 | 87,000,000 | 89,000,000 | 66,500 | 88,000 | 85,000 | 93,000,000 | -118,782,000 | 57,000,000 | 33,000,000 | 29,000 | 11,000,000 | 9,000,000 | 19,000,000 | 16,000,000 | 5,000,000 | 3,000,000 | 2,000,000 | 3,000,000 | 2,000,000 | 3,000 | 2,000 | 2,000 | 4,000 | 1,000 | 2,000 | 2,000 | 1,000 | 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net operating revenues before benefit from doubtful accounts | 3,827,500,000 | 4,941,000,000 | 5,173,000,000 | 5,196,000,000 | 21,054,144,000 | 5,216,000 | 5,220,000 | 5,420,000,000 | -14,673,889,000 | 5,063,000,000 | 4,844,000,000 | 4,791,000 | -13,078,080,000 | 4,428,000,000 | 4,362,000,000 | 4,306,000,000 | -7,828,926,000 | 2,618,000,000 | 2,629,000,000 | 2,594,000,000 | -7,363,096,000 | 2,427,000,000 | 2,455,000,000 | 2,543,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: benefit from doubtful accounts | 277,250,000 | 355,000,000 | 371,000,000 | 383,000,000 | 1,447,905,000 | 367,000 | 352,000 | 376,000,000 | -1,084,523,000 | 371,000,000 | 352,000,000 | 363,000 | -947,695,000 | 249,000,000 | 320,000,000 | 380,000,000 | -623,028,000 | 210,000,000 | 207,000,000 | 207,000,000 | -584,215,000 | 206,000,000 | 190,000,000 | 193,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from early extinguishment of debt | -41,000,000 | -138,000,000 | -26,000,000 | 23,976,000 | -24,000,000 | 15,000 | 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from continuing operations, before income taxes | -81,250,000 | -348,000,000 | 19,000,000 | 4,000,000 | 54,750 | 89,000 | 25,000 | 105,000,000 | -76,856,000 | 40,000,000 | -54,000,000 | 91,000 | -5,853,000 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from continuing operations, before discontinued operations | -55,000,000 | -288,000,000 | 31,000,000 | 37,000,000 | 39,500 | 79,000 | 41,000 | 38,000,000 | -76,924,000 | 29,000,000 | -27,000,000 | 75,000 | -16,902,000 | 19,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from discontinued operations | -250,000 | -1,000,000 | 1,000,000 | 1,000 | 1,000 | 21,978,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to tenet healthcare corporation common shareholders | -118,750,000 | -367,000,000 | -55,000,000 | -53,000,000 | -28,250 | -46,000 | -61,000,000 | 47,000 | 49,012,000 | 9,000,000 | -26,000,000 | -32,000,000 | 109,866,000 | 28,000,000 | -50,000,000 | -88,000,000 | -91,859,000 | 40,000,000 | -6,000,000 | 58,000,000 | 33,500,000 | 6,000,000 | 55,000,000 | 73,000 | 74,000 | 932,000 | 25,000 | 88,000 | 21,000 | -3,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts attributable to tenet healthcare corporation common shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from continuing operations, net of tax | -118,500,000 | -366,000,000 | -56,000,000 | -52,000,000 | -27,000 | -44,000 | -55,000,000 | 41,858,000 | -28,000,000 | -60,000,000 | 46,000 | 27,034,000 | 10,000,000 | -27,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from discontinued operations, net of tax | -250,000 | -1,000,000 | 1,000,000 | 1,000 | 1,000 | 21,978,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per share attributable to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment earnings | 7,998,000 | 2,000 | 1,000,000 | 1,000,000 | -999,000 | 1,000,000 | -1,999,000 | 1,000,000 | 1,000,000 | -2,997,000 | 1,000,000 | 1,000,000 | 1,000 | 3,000 | 1,000 | 1,000 | -250 | 2,000 | -5,000 | 2,000 | 21,979,000 | 12,000 | 4,000 | 5,000 | 11,000,000 | 10,000,000 | 15,000,000 | 11,000,000 | 15,000 | 17,000 | 17,000 | 15,000 | 9,000 | 6,000 | 3,000 | 3,000 | 4,000 | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share attributable to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets and goodwill, and restructuring charges | -11,981,000 | 6,000,000 | 3,000,000 | 3,000,000 | -17,973,000 | 8,000,000 | 2,000,000 | 8,000 | -2,000 | 3,000 | -2,000 | 3,250 | 7,000 | 1,000 | 5,000 | 1,000 | 1,000 | 2,000 | 1,000 | 3,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gains on sales of facilities | -999,000 | 2,000,000 | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: preferred stock dividends | -10,989,000 | 1,000,000 | 4,000,000 | 6,000,000 | 4,500,000 | 6,000,000 | 6,000,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations | 0.01 | 0.01 | -0.01 | 0.01 | -0.01 | 0.01 | 0.02 | 0.08 | 0.02 | 0.01 | -0.003 | -0.01 | 0.01 | -0.01 | -0.013 | 0.01 | -0.02 | -0.04 | 0.03 | -0.01 | -0.01 | 0.01 | -0.058 | -0.01 | 0.03 | 0.09 | 0.003 | 0.03 | -0.02 | 0.04 | -0.02 | 0.01 | 0.02 | -0.01 | -0.04 | -0.02 | -0.008 | -0.02 | 0.01 | -0.04 | 120 | ||||||||||||||||||||||||||||||||||||||||||||||
earnings per share attributable to tenet healthcare corporation common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share attributable to tenet healthcare corporation common shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from doubtful accounts | 136,500,000 | 193,000,000 | 171,000,000 | 182,000 | 191,000 | 187,000 | 173,000 | 189,000 | 181,000 | 193,000 | 167,000 | 156,000 | 631,534,000 | 166,000 | 154,000 | 149,000 | 134,000,000 | 159,000,000 | 151,000,000 | 141,000,000 | 157,000 | 138,000 | 206,000 | 153,000 | 158,000 | 253,000 | 499,000 | 522,000 | 288,000 | 304,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain from early extinguishment of debt | -2,000 | -55,000 | -16,000 | -21,000 | 134,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sales of investments | 15,000 | 35,000 | 140,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net incomees on sales of facilities | -2,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
litigation and investigation costs (benefit), net of insurance recoveries | 3,250 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
litigation settlements, net of insurance recoveries | 9,750 | 39,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to tenet healthcare corporation shareholders | -15,000 | 178,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts attributable to tenet healthcare corporation shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share attributable to tenet healthcare corporation shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share attributable to tenet healthcare corporation shareholders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interests | -5,997,000 | -2,000 | -1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sales of facilities | 1,250 | -3,000 | 8,000 | 2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation | 86,000 | 85,000,000 | 83,000,000 | 81,000,000 | 81,000,000 | 77,000 | 83,000 | 95,000 | 86,000 | 90,000 | 93,000 | 107,000 | 113,000 | 125,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization | 9,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 6,000 | 7,000 | 10,000 | 6,000 | 6,000 | 6,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income on sales of facilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries | 36,000,000 | 13,000,000 | 10,000,000 | 1,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
hurricane insurance recoveries, net of costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gains on sales of investments | 2,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax (expense) benefit | 19,500,000 | 92,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations, before discontinued operations and cumulative effect of change in accounting principle | 9,250,000 | 93,000,000 | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before cumulative effect of change in accounting principle | 75,000,000 | 68,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cumulative effect of change in accounting principle, net of tax | 2,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted earnings (loss) per common share and common equivalent share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss from continuing operations, before income taxes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income (loss) from continuing operations, before discontinued operations and cumulative effect of change in accounting principle | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income (loss) from discontinued operations, net of tax | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income (loss) before cumulative effect of change in accounting principle | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted earnings per common share and common equivalent share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted average shares and dilutive securities outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 473,212,000,000 | 472,136,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 473,212,000,000 | 474,326,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
costs of litigation and investigations | 7,000 | 16,000 | 28,000 | 11,000 | 8,000 | 10,000 | 9,000 | 253,000 | 68,000 | 4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from operations of asset group | 13,000 | 7,000 | 11,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sales of asset group | 3,000 | 22,000 | 4,000 | 31,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per common share and common equivalent share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets and restructuring charges | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from hurricanes and related costs | 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
insurance recovery | 45,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gains on sales of asset group | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per common share and common equivalent share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | -120,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations | 0.01 | 0.01 | -0.01 | 0.01 | -0.01 | 0.01 | 0.02 | 0.08 | 0.02 | 0.01 | -0.003 | -0.01 | 0.01 | -0.01 | -0.013 | 0.01 | -0.02 | -0.04 | 0.03 | -0.01 | -0.01 | 0.01 | -0.058 | -0.01 | 0.03 | 0.09 | 0.003 | 0.03 | -0.02 | 0.04 | -0.02 | 0.01 | 0.02 | -0.01 | -0.04 | -0.02 | -0.008 | -0.02 | 0.01 | -0.04 | 120 | ||||||||||||||||||||||||||||||||||||||||||||||
diluted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment and restructuring charges | 205,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from hurricane and related costs | 40,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sales of long-term investments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations before income taxes | 3,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations | 20,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per common share and common equivalent share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
salaries and benefits | 1,124,000 | 1,078,000 | 1,131,000 | 1,420,000 | 1,474,000 | 1,451,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restructuring charges | 9,000 | 2,000 | 22,000 | 8,000 | 77,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets and goodwill | 21,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sale of subsidiary common stock and long-term investments | 6,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of investment securities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss per common share and common equivalent share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
goodwill amortization | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other amortization | 5,000 | 7,000 | 7,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of goodwill and long-lived assets | 1,000 | 198,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of subsidiary common stock | 9,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment charges | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per common share and common equivalent share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | -120,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets | 383,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restructuring and other unusual charges | 15,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income (loss) before income taxes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes | 31,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per common share and common equivalent share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | -120,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-09-30 | 2004-06-30 | 2003-09-30 | 2003-06-30 | 2003-02-28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 2,967,000,000 | 2,883,000,000 | 2,975,000,000 | 2,625,000,000 | 2,999,000,000 | 3,019,000,000 | 4,094,000,000 | 2,880,000,000 | 2,481,000,000 | 1,228,000,000 | 1,054,000,000 | 934,000,000 | 766,000,000 | 858,000,000 | 1,208,000,000 | 1,351,000,000 | 1,405,000,000 | 2,364,000,000 | 2,292,000,000 | 2,194,000,000 | 2,141,000,000 | 3,300,000,000 | 3,514,000,000 | 613,000,000 | 314,000,000 | 249,000,000 | 252,000,000 | 500,000,000 | 403,000,000 | 974,000,000 | 429,000,000 | 475,000,000 | 572,000,000 | 716,000,000 | 649,000,000 | 656,000,000 | 728,000,000 | 356,000,000 | 450,000,000 | 299,000,000 | 185,000,000 | 193,000,000 | 200,000,000 | 406,000,000 | 141,000,000 | 113,000,000 | 82,000,000 | 90,000,000 | 95,000,000 | 364,000,000 | 83,000,000 | 82,000,000 | 104,000,000 | 185,000,000 | 264,000,000 | 267,000,000 | 405,000,000 | 398,000,000 | 711,000,000 | 589,000,000 | 690,000,000 | 731,000,000 | 758,000,000 | 652,000,000 | 512,000,000 | 352,000,000 | 278,000,000 | 655,000,000 | 675,000,000 | 584,000,000 | 809,000,000 | 568,000,000 | 975,000,000 | 1,480,000,000 | 1,594,000,000 | 1,497,000,000 | 1,323,000,000 | 1,193,000,000 | 219,000,000 | 221,000,000 | 118,000,000 | |||||||||
accounts receivable | 2,605,000,000 | 2,565,000,000 | 2,518,000,000 | 2,533,000,000 | 2,619,000,000 | 2,536,000,000 | 2,598,000,000 | 2,817,000,000 | 3,148,000,000 | 2,914,000,000 | 2,897,000,000 | 2,914,000,000 | 2,883,000,000 | 2,943,000,000 | 2,826,000,000 | 2,840,000,000 | 2,916,000,000 | 2,770,000,000 | 2,742,000,000 | 2,643,000,000 | 2,745,000,000 | 2,479,000,000 | 2,435,000,000 | 2,722,000,000 | 2,768,000,000 | 2,734,000,000 | 2,744,000,000 | 2,484,000,000 | 2,483,000,000 | 2,519,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
inventories of supplies, at cost | 343,000,000 | 348,000,000 | 346,000,000 | 338,000,000 | 344,000,000 | 346,000,000 | 356,000,000 | 382,000,000 | 395,000,000 | 411,000,000 | 413,000,000 | 404,000,000 | 407,000,000 | 405,000,000 | 394,000,000 | 387,000,000 | 391,000,000 | 384,000,000 | 376,000,000 | 364,000,000 | 368,000,000 | 349,000,000 | 337,000,000 | 324,000,000 | 311,000,000 | 309,000,000 | 308,000,000 | 307,000,000 | 298,000,000 | 294,000,000 | 297,000,000 | 316,000,000 | 324,000,000 | 326,000,000 | 322,000,000 | 316,000,000 | 312,000,000 | 309,000,000 | 275,000,000 | 261,000,000 | 268,000,000 | 276,000,000 | 270,000,000 | 264,000,000 | 261,000,000 | 262,000,000 | 154,000,000 | 153,000,000 | 152,000,000 | 153,000,000 | 154,000,000 | 154,000,000 | 157,000,000 | 157,000,000 | 156,000,000 | 156,000,000 | 156,000,000 | 152,000,000 | 152,000,000 | 151,000,000 | 153,000,000 | 153,000,000 | 154,000,000 | 158,000,000 | 165,000,000 | 170,000,000 | 182,000,000 | 181,000,000 | 184,000,000 | 180,000,000 | 177,000,000 | 174,000,000 | 194,000,000 | 187,000,000 | 193,000,000 | 190,000,000 | 187,000,000 | 187,000,000 | 224,000,000 | 220,000,000 | 242,000,000 | |||||||||
assets held for sale | 62,000,000 | 62,000,000 | 82,000,000 | 21,000,000 | 21,000,000 | 21,000,000 | 20,000,000 | 21,000,000 | 22,000,000 | 775,000,000 | 140,000,000 | 141,000,000 | 142,000,000 | 19,000,000 | 828,000,000 | 139,000,000 | 386,000,000 | 378,000,000 | 394,000,000 | 128,000,000 | 452,000,000 | 599,000,000 | 842,000,000 | 705,000,000 | 3,000,000 | 29,000,000 | 17,000,000 | 2,000,000 | 2,000,000 | 550,000,000 | 1,186,000,000 | 1,170,000,000 | 337,000,000 | 41,000,000 | 2,000,000 | 2,000,000 | 11,000,000 | 13,000,000 | 14,000,000 | 20,000,000 | 19,000,000 | 31,000,000 | 29,000,000 | 37,000,000 | 39,000,000 | 35,000,000 | 362,000,000 | 385,000,000 | 19,000,000 | 60,000,000 | 66,000,000 | 70,000,000 | 171,000,000 | 303,000,000 | 9,000,000 | 29,000,000 | 74,000,000 | 63,000,000 | 565,000,000 | 670,000,000 | 476,000,000 | 565,000,000 | ||||||||||||||||||||||||||||
other current assets | 2,379,000,000 | 1,991,000,000 | 1,889,000,000 | 1,781,000,000 | 1,930,000,000 | 1,760,000,000 | 1,691,000,000 | 1,855,000,000 | 1,775,000,000 | 1,839,000,000 | 1,855,000,000 | 1,602,000,000 | 1,671,000,000 | 1,775,000,000 | 1,566,000,000 | 1,468,000,000 | 1,397,000,000 | 1,557,000,000 | 1,495,000,000 | 1,388,000,000 | 1,306,000,000 | 1,292,000,000 | 1,265,000,000 | 1,317,000,000 | 1,378,000,000 | 1,393,000,000 | 1,261,000,000 | 1,046,000,000 | 1,041,000,000 | 1,228,000,000 | 1,160,000,000 | 1,173,000,000 | 1,167,000,000 | 1,285,000,000 | 1,331,000,000 | 1,282,000,000 | 1,280,000,000 | 1,245,000,000 | 1,202,000,000 | 1,110,000,000 | 1,146,000,000 | 1,095,000,000 | 746,000,000 | 700,000,000 | 839,000,000 | 716,000,000 | 583,000,000 | 600,000,000 | 455,000,000 | 458,000,000 | 502,000,000 | 509,000,000 | 386,000,000 | 357,000,000 | 375,000,000 | 412,000,000 | 288,000,000 | 415,000,000 | 271,000,000 | 270,000,000 | 286,000,000 | 324,000,000 | 294,000,000 | 307,000,000 | 282,000,000 | 266,000,000 | 265,000,000 | 233,000,000 | 215,000,000 | 232,000,000 | 226,000,000 | 239,000,000 | 273,000,000 | 284,000,000 | 321,000,000 | 289,000,000 | 305,000,000 | 289,000,000 | 375,000,000 | 334,000,000 | 401,000,000 | |||||||||
total current assets | 8,356,000,000 | 7,849,000,000 | 7,810,000,000 | 7,298,000,000 | 7,913,000,000 | 7,682,000,000 | 8,759,000,000 | 7,955,000,000 | 7,821,000,000 | 7,167,000,000 | 6,359,000,000 | 5,995,000,000 | 5,869,000,000 | 5,981,000,000 | 5,998,000,000 | 6,064,000,000 | 6,128,000,000 | 7,075,000,000 | 6,905,000,000 | 7,417,000,000 | 6,699,000,000 | 488,074,000 | 7,808,000,000 | 7,947,000,000 | 5,388,000,000 | 277,532,000 | 4,789,000,000 | 4,704,000,000 | 4,582,000,000 | 285,478,000 | 4,492,000,000 | 4,705,000,000 | 5,634,000,000 | 211,487,000 | 5,309,000,000 | 5,382,000,000 | 5,052,000,000 | 5,257,000,000 | 5,116,000,000 | 4,993,000,000 | 5,129,000,000 | 5,171,000,000 | 6,296,000,000 | 6,009,000,000 | 5,124,000,000 | 4,717,000,000 | 4,201,000,000 | 4,208,000,000 | 3,978,000,000 | 3,710,000,000 | 2,560,000,000 | 2,574,000,000 | 2,443,000,000 | 2,681,000,000 | 2,484,000,000 | 2,564,000,000 | 2,482,000,000 | 2,176,000,000 | 2,314,000,000 | 2,393,000,000 | 2,311,000,000 | 2,444,000,000 | 2,435,000,000 | 2,386,000,000 | 2,472,000,000 | 2,539,000,000 | 2,562,000,000 | 2,631,000,000 | 2,836,000,000 | 2,778,000,000 | 2,317,000,000 | 2,593,000,000 | 2,608,000,000 | 2,753,000,000 | 3,138,000,000 | 3,349,000,000 | 3,078,000,000 | 4,026,000,000 | 4,130,000,000 | 4,121,000,000 | 4,887,000,000 | 4,928,000,000 | 4,223,000,000 | 4,281,000,000 | 3,706,000,000 | |||||
investments and other assets | 3,809,000,000 | 2,883,000,000 | 2,939,000,000 | 2,994,000,000 | 3,069,000,000 | 3,037,000,000 | 3,064,000,000 | 3,156,000,000 | 3,244,000,000 | 3,157,000,000 | 3,152,000,000 | 3,130,000,000 | 3,175,000,000 | 3,147,000,000 | 3,312,000,000 | 3,297,000,000 | 3,385,000,000 | 3,254,000,000 | 2,564,000,000 | 2,525,000,000 | 2,577,000,000 | 2,445,000,000 | 2,464,000,000 | 2,467,000,000 | 2,380,000,000 | 2,297,000,000 | 2,331,000,000 | 1,462,000,000 | 1,416,000,000 | 1,433,000,000 | 1,253,000,000 | 1,238,000,000 | 1,260,000,000 | 1,250,000,000 | 1,324,000,000 | 1,317,000,000 | 1,142,000,000 | 1,175,000,000 | 1,029,000,000 | 1,017,000,000 | 355,000,000 | 384,000,000 | 366,000,000 | 362,000,000 | 355,000,000 | 405,000,000 | 184,000,000 | 166,000,000 | 163,000,000 | 162,000,000 | 126,000,000 | 120,000,000 | 153,000,000 | 159,000,000 | 171,000,000 | 162,000,000 | 164,000,000 | 176,000,000 | 180,000,000 | 185,000,000 | 182,000,000 | 181,000,000 | 198,000,000 | 255,000,000 | 282,000,000 | 271,000,000 | 322,000,000 | 369,000,000 | 417,000,000 | 390,000,000 | 369,000,000 | 365,000,000 | 364,000,000 | 302,000,000 | 300,000,000 | 298,000,000 | 308,000,000 | 305,000,000 | 299,000,000 | 295,000,000 | 292,000,000 | |||||||||
deferred income taxes | 84,000,000 | 84,000,000 | 72,000,000 | 76,000,000 | 78,000,000 | 80,000,000 | 36,000,000 | 85,000,000 | 20,000,000 | 77,000,000 | 4,000,000 | 8,000,000 | 14,000,000 | 19,000,000 | 55,000,000 | 60,000,000 | 2,000,000 | 65,000,000 | 140,000,000 | 276,000,000 | 297,000,000 | 436,000,000 | 232,000,000 | 263,000,000 | 252,000,000 | 268,000,000 | 291,000,000 | 348,000,000 | 348,000,000 | 383,000,000 | 783,000,000 | 1,020,000,000 | 930,000,000 | 871,000,000 | 840,000,000 | 797,000,000 | 726,000,000 | 776,000,000 | 107,000,000 | 107,000,000 | 108,000,000 | 80,000,000 | 83,000,000 | 82,000,000 | 91,000,000 | 118,000,000 | 84,000,000 | 71,000,000 | 63,000,000 | 49,000,000 | 113,000,000 | 113,000,000 | 33,000,000 | 195,000,000 | 104,000,000 | 112,000,000 | 445,000,000 | 442,000,000 | 361,000,000 | 171,000,000 | 186,000,000 | |||||||||||||||||||||||||||||
property and equipment, at cost, less accumulated depreciation and amortization | 6,251,000,000 | 6,315,000,000 | 6,091,000,000 | 6,024,000,000 | 5,991,000,000 | 6,049,000,000 | 5,552,000,000 | 5,857,000,000 | 5,855,000,000 | 6,236,000,000 | 6,260,000,000 | 6,268,000,000 | 6,319,000,000 | 6,462,000,000 | 6,291,000,000 | 6,259,000,000 | 6,296,000,000 | 6,427,000,000 | 6,162,000,000 | 6,166,000,000 | 6,592,000,000 | 6,618,000,000 | 6,703,000,000 | 6,786,000,000 | 7,001,000,000 | 6,995,000,000 | 6,996,000,000 | 6,888,000,000 | 6,863,000,000 | 6,906,000,000 | 7,077,000,000 | 7,738,000,000 | 7,976,000,000 | 8,053,000,000 | 7,965,000,000 | 7,977,000,000 | 7,961,000,000 | 7,915,000,000 | 7,330,000,000 | 7,135,000,000 | 7,528,000,000 | 7,733,000,000 | 7,749,000,000 | 7,771,000,000 | 7,723,000,000 | 7,691,000,000 | 4,354,000,000 | 4,326,000,000 | 4,296,000,000 | 4,293,000,000 | 4,173,000,000 | 4,181,000,000 | 4,324,000,000 | 4,201,000,000 | 4,238,000,000 | 4,262,000,000 | 4,304,000,000 | 4,239,000,000 | 4,211,000,000 | 4,249,000,000 | 4,313,000,000 | 4,172,000,000 | 4,182,000,000 | 4,236,000,000 | 4,239,000,000 | 4,274,000,000 | 4,622,000,000 | 4,403,000,000 | 4,354,000,000 | 4,275,000,000 | 4,317,000,000 | 4,276,000,000 | 4,601,000,000 | 4,593,000,000 | 4,849,000,000 | 4,817,000,000 | ||||||||||||||
goodwill | 11,387,000,000 | 11,198,000,000 | 11,158,000,000 | 10,935,000,000 | 10,786,000,000 | 10,691,000,000 | 10,588,000,000 | 10,799,000,000 | 10,568,000,000 | 10,307,000,000 | 10,415,000,000 | 10,350,000,000 | 10,258,000,000 | 10,123,000,000 | 9,979,000,000 | 9,479,000,000 | 9,352,000,000 | 9,261,000,000 | 8,662,000,000 | 8,659,000,000 | 8,799,000,000 | 7,302,000,000 | 7,301,000,000 | 7,308,000,000 | 7,315,000,000 | 7,298,000,000 | 7,283,000,000 | 7,313,000,000 | 7,218,000,000 | 7,036,000,000 | 7,022,000,000 | 7,157,000,000 | 7,429,000,000 | 7,425,000,000 | 7,376,000,000 | 7,291,000,000 | 7,122,000,000 | 6,970,000,000 | 6,606,000,000 | 6,602,000,000 | 3,874,000,000 | 3,913,000,000 | 3,705,000,000 | 3,200,000,000 | 3,070,000,000 | 3,042,000,000 | 1,120,000,000 | 970,000,000 | 948,000,000 | 916,000,000 | 771,000,000 | 749,000,000 | 738,000,000 | 724,000,000 | 715,000,000 | 677,000,000 | 652,000,000 | 637,000,000 | 609,000,000 | 607,000,000 | 607,000,000 | 607,000,000 | 607,000,000 | 609,000,000 | 609,000,000 | 610,000,000 | 607,000,000 | 600,000,000 | 603,000,000 | 601,000,000 | 753,000,000 | 753,000,000 | 800,000,000 | 800,000,000 | 800,000,000 | 800,000,000 | 1,913,000,000 | 1,913,000,000 | 2,885,000,000 | 2,880,000,000 | 3,260,000,000 | |||||||||
other intangible assets, at cost, less accumulated amortization | 1,316,000,000 | 1,348,000,000 | 1,348,000,000 | 1,372,000,000 | 1,400,000,000 | 1,397,000,000 | 1,373,000,000 | 1,413,000,000 | 1,399,000,000 | 1,368,000,000 | 1,400,000,000 | 1,406,000,000 | 1,432,000,000 | 1,424,000,000 | 1,441,000,000 | 1,462,000,000 | 1,487,000,000 | 1,497,000,000 | 1,480,000,000 | 1,522,000,000 | 1,590,000,000 | 1,578,000,000 | 1,603,000,000 | 1,611,000,000 | 1,620,000,000 | 1,645,000,000 | 1,675,000,000 | 1,762,000,000 | 1,793,000,000 | 1,792,000,000 | 1,764,000,000 | 1,806,000,000 | 1,863,000,000 | 1,845,000,000 | 1,853,000,000 | 1,865,000,000 | 1,686,000,000 | 1,675,000,000 | 1,830,000,000 | 1,894,000,000 | 1,478,000,000 | 1,278,000,000 | 1,191,000,000 | 1,241,000,000 | 1,229,000,000 | 1,192,000,000 | 723,000,000 | 700,000,000 | 670,000,000 | 650,000,000 | 578,000,000 | 526,000,000 | 506,000,000 | 500,000,000 | 454,000,000 | 441,000,000 | 442,000,000 | 403,000,000 | 399,000,000 | 388,000,000 | 379,000,000 | 377,000,000 | 379,000,000 | 361,000,000 | 328,000,000 | 310,000,000 | 306,000,000 | 270,000,000 | 271,000,000 | 256,000,000 | 202,000,000 | 194,000,000 | 231,000,000 | 246,000,000 | 180,000,000 | 179,000,000 | 156,000,000 | 160,000,000 | 185,000,000 | |||||||||||
total assets | 31,203,000,000 | 29,677,000,000 | 29,418,000,000 | 28,699,000,000 | 29,237,000,000 | 28,936,000,000 | 29,372,000,000 | 29,265,000,000 | 28,907,000,000 | 28,312,000,000 | 27,590,000,000 | 27,157,000,000 | 27,067,000,000 | 27,156,000,000 | 27,076,000,000 | 26,621,000,000 | 26,650,000,000 | 27,579,000,000 | 25,913,000,000 | 26,565,000,000 | 26,554,000,000 | 1,388,800,000 | 26,187,000,000 | 26,250,000,000 | 23,823,000,000 | 952,371,000 | 23,357,000,000 | 23,207,000,000 | 23,158,000,000 | 967,291,000 | 22,265,000,000 | 22,343,000,000 | 23,184,000,000 | 642,907,000 | 23,208,000,000 | 24,341,000,000 | 24,510,000,000 | 24,701,000,000 | 24,474,000,000 | 24,240,000,000 | 23,766,000,000 | 23,682,000,000 | 23,173,000,000 | 22,746,000,000 | 18,425,000,000 | 18,141,000,000 | 17,312,000,000 | 16,907,000,000 | 16,484,000,000 | 16,130,000,000 | 9,337,000,000 | 9,156,000,000 | 8,915,000,000 | 9,044,000,000 | 8,470,000,000 | 8,485,000,000 | 8,545,000,000 | 8,462,000 | 8,293,000,000 | 8,435,000,000 | 8,524,000,000 | 8,500,000,000 | 8,535,000,000 | 7,834,000,000 | 7,815,000,000 | 7,953,000,000 | 7,876,000,000 | 7,928,000,000 | 8,092,000,000 | 8,294,000,000 | 8,243,000,000 | 8,174,000,000 | 8,393,000 | 8,235,000,000 | 8,253,000,000 | 8,275,000,000 | 9,042,000,000 | 9,200,000,000 | 9,337,000,000 | 9,967,000,000 | 10,259,000,000 | 12,126,000,000 | 12,150,000,000 | |||||||
liabilities and equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of long-term debt | 81,000,000 | 79,000,000 | 85,000,000 | 84,000,000 | 88,000,000 | 92,000,000 | 95,000,000 | 102,000,000 | 107,000,000 | 120,000,000 | 141,000,000 | 141,000,000 | 148,000,000 | 145,000,000 | 131,000,000 | 125,000,000 | 132,000,000 | 135,000,000 | 125,000,000 | 127,000,000 | 137,000,000 | 155,000,000 | 160,000,000 | 165,000,000 | 165,000,000 | 664,000,000 | 158,000,000 | 672,000,000 | 663,000,000 | 666,000,000 | 140,000,000 | 143,000,000 | 147,000,000 | 191,000,000 | 184,000,000 | 181,000,000 | 172,000,000 | 127,000,000 | 112,000,000 | 117,000,000 | 110,000,000 | 112,000,000 | 98,000,000 | 622,000,000 | 622,000,000 | 149,000,000 | 133,000,000 | 71,000,000 | 52,000,000 | 94,000,000 | 243,000,000 | 237,000,000 | 288,000,000 | 129,000,000 | 128,000,000 | 68,000,000 | 67,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 1,000,000 | 22,000,000 | 22,000,000 | 38,000,000 | 19,000,000 | 19,000,000 | 20,000,000 | 20,000,000 | 19,000,000 | 26,000,000 | 26,000,000 | 23,000,000 | 23,000,000 | 41,000,000 | |||||||||
accounts payable | 1,339,000,000 | 1,360,000,000 | 1,356,000,000 | 1,360,000,000 | 1,327,000,000 | 1,294,000,000 | 1,265,000,000 | 1,270,000,000 | 1,335,000,000 | 1,408,000,000 | 1,202,000,000 | 1,246,000,000 | 1,192,000,000 | 1,504,000,000 | 1,240,000,000 | 1,083,000,000 | 1,114,000,000 | 1,300,000,000 | 1,100,000,000 | 1,084,000,000 | 1,103,000,000 | 1,025,000,000 | 1,018,000,000 | 1,079,000,000 | 1,125,000,000 | 1,088,000,000 | 1,101,000,000 | 1,065,000,000 | 1,047,000,000 | 1,059,000,000 | 46,092,000 | 1,100,000,000 | 1,086,000,000 | 1,179,000,000 | 1,329,000,000 | 1,228,000,000 | 1,272,000,000 | 1,228,000,000 | 1,380,000,000 | 1,206,000,000 | 1,149,000,000 | 1,098,000,000 | 1,179,000,000 | 1,068,000,000 | 1,015,000,000 | 1,019,000,000 | 1,075,000,000 | 618,000,000 | 587,000,000 | 625,000,000 | 722,000,000 | 629,000,000 | 644,000,000 | 640,000,000 | 629,000,000 | 614,000,000 | 638,000,000 | 720,000,000 | 601,000,000 | 615,000,000 | 615,000,000 | 739,000,000 | 638,000,000 | 618,000,000 | 650,000,000 | 632,000,000 | 643,000,000 | 633,000,000 | 637,000,000 | 642,000,000 | 664,000,000 | 749,000,000 | 761,000,000 | 776,000,000 | 806,000,000 | 744,000,000 | 774,000,000 | 839,000,000 | 853,000,000 | 870,000,000 | 911,000,000 | 966,000,000 | ||||||||
accrued compensation and benefits | 854,000,000 | 858,000,000 | 857,000,000 | 793,000,000 | 710,000,000 | 899,000,000 | 879,000,000 | 788,000,000 | 775,000,000 | 930,000,000 | 787,000,000 | 718,000,000 | 602,000,000 | 778,000,000 | 781,000,000 | 811,000,000 | 813,000,000 | 896,000,000 | 1,071,000,000 | 954,000,000 | 907,000,000 | 834,000,000 | 699,000,000 | 788,000,000 | 842,000,000 | 720,000,000 | 707,000,000 | 814,000,000 | 711,000,000 | 708,000,000 | 800,000,000 | 749,000,000 | 739,000,000 | 872,000,000 | 809,000,000 | 843,000,000 | 772,000,000 | 880,000,000 | 821,000,000 | 770,000,000 | 671,000,000 | 852,000,000 | 735,000,000 | 669,000,000 | 595,000,000 | 631,000,000 | 383,000,000 | 402,000,000 | 373,000,000 | 415,000,000 | 379,000,000 | 363,000,000 | 338,000,000 | 349,000,000 | 357,000,000 | 368,000,000 | 363,000,000 | 385,000,000 | 343,000,000 | 347,000,000 | 370,000,000 | 380,000,000 | 330,000,000 | 328,000,000 | 391,000,000 | 338,000,000 | 328,000,000 | 362,000,000 | 333,000,000 | 324,000,000 | 356,000,000 | 335,000,000 | 329,000,000 | 391,000,000 | 412,000,000 | 347,000,000 | 448,000,000 | 480,000,000 | 480,000,000 | 565,000,000 | 561,000,000 | |||||||||
professional and general liability reserves | 303,000,000 | 276,000,000 | 287,000,000 | 275,000,000 | 268,000,000 | 238,000,000 | 286,000,000 | 283,000,000 | 266,000,000 | 254,000,000 | 264,000,000 | 257,000,000 | 256,000,000 | 255,000,000 | 279,000,000 | 272,000,000 | 272,000,000 | 254,000,000 | 268,000,000 | 234,000,000 | 263,000,000 | 285,000,000 | 292,000,000 | 279,000,000 | 230,000,000 | 228,000,000 | 224,000,000 | 230,000,000 | 230,000,000 | 222,000,000 | 210,000,000 | 208,000,000 | 201,000,000 | 181,000,000 | 185,000,000 | 179,000,000 | 161,000,000 | 177,000,000 | 185,000,000 | 204,000,000 | 188,000,000 | 189,000,000 | 175,000,000 | 162,000,000 | 140,000,000 | 156,000,000 | 74,000,000 | 84,000,000 | 49,000,000 | 64,000,000 | 72,000,000 | 73,000,000 | 63,000,000 | 79,000,000 | 96,000,000 | 104,000,000 | 84,000,000 | 91,000,000 | 104,000,000 | 106,000,000 | 106,000,000 | 114,000,000 | 113,000,000 | 116,000,000 | 150,000,000 | 150,000,000 | 161,000,000 | 148,000,000 | 140,000,000 | 145,000,000 | 145,000,000 | 136,000,000 | 150,000,000 | |||||||||||||||||
accrued interest payable | 256,000,000 | 81,000,000 | 248,000,000 | 148,000,000 | 248,000,000 | 149,000,000 | 248,000,000 | 149,000,000 | 249,000,000 | 200,000,000 | 273,000,000 | 199,000,000 | 248,000,000 | 213,000,000 | 249,000,000 | 221,000,000 | 255,000,000 | 203,000,000 | 262,000,000 | 220,000,000 | 290,000,000 | 218,000,000 | 257,000,000 | 306,000,000 | 252,000,000 | 233,000,000 | 323,000,000 | 330,000,000 | 243,000,000 | 332,000,000 | 336,000,000 | 238,000,000 | 327,000,000 | 210,000,000 | 308,000,000 | 205,000,000 | 307,000,000 | 205,000,000 | 307,000,000 | 204,000,000 | 268,000,000 | 194,000,000 | 265,000,000 | 207,000,000 | 274,000,000 | 198,000,000 | 109,000,000 | 91,000,000 | 99,000,000 | 125,000,000 | 110,000,000 | 121,000,000 | 103,000,000 | 111,000,000 | 117,000,000 | 116,000,000 | 115,000,000 | 110,000,000 | 123,000,000 | 114,000,000 | 127,000,000 | 123,000,000 | 104,000,000 | 77,000,000 | 97,000,000 | 125,000,000 | 97,000,000 | 110,000,000 | 136,000,000 | 105,000,000 | 98,000,000 | 125,000,000 | 96,000,000 | 96,000,000 | 125,000,000 | 96,000,000 | ||||||||||||||
income tax payable | 236,000,000 | 28,000,000 | 25,000,000 | 149,000,000 | 18,000,000 | 826,000,000 | 715,000,000 | 805,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other current liabilities | 3,083,000,000 | 1,809,000,000 | 1,687,000,000 | 1,574,000,000 | 1,649,000,000 | 1,607,000,000 | 1,927,000,000 | 2,175,000,000 | 1,868,000,000 | 1,779,000,000 | 1,662,000,000 | 1,498,000,000 | 1,674,000,000 | 1,471,000,000 | 1,485,000,000 | 1,382,000,000 | 1,306,000,000 | 1,362,000,000 | 1,335,000,000 | 1,252,000,000 | 1,245,000,000 | 1,735,000,000 | 1,570,000,000 | 1,429,000,000 | 1,314,000,000 | 1,217,000,000 | 1,212,000,000 | 1,042,000,000 | 1,067,000,000 | 1,168,000,000 | 1,146,000,000 | 1,861,000,000 | 1,163,000,000 | 1,234,000,000 | 1,293,000,000 | 1,225,000,000 | 1,205,000,000 | 1,144,000,000 | 1,236,000,000 | 1,086,000,000 | 954,000,000 | 1,051,000,000 | 804,000,000 | 709,000,000 | 686,000,000 | 719,000,000 | 452,000,000 | 423,000,000 | 351,000,000 | 335,000,000 | 389,000,000 | 427,000,000 | 352,000,000 | 372,000,000 | 340,000,000 | 350,000,000 | 368,000,000 | 499,000,000 | 340,000,000 | 340,000,000 | 363,000,000 | 419,000,000 | 364,000,000 | 494,000,000 | 536,000,000 | 548,000,000 | 485,000,000 | 502,000,000 | 477,000,000 | 485,000,000 | 367,000,000 | 349,000,000 | 349,000,000 | 407,000,000 | 415,000,000 | 451,000,000 | 580,000,000 | 529,000,000 | 746,000,000 | 749,000,000 | 643,000,000 | |||||||||
total current liabilities | 6,152,000,000 | 4,463,000,000 | 4,560,000,000 | 4,271,000,000 | 4,451,000,000 | 4,310,000,000 | 5,538,000,000 | 5,493,000,000 | 5,416,000,000 | 4,760,000,000 | 4,432,000,000 | 4,152,000,000 | 4,219,000,000 | 4,476,000,000 | 4,276,000,000 | 4,368,000,000 | 4,668,000,000 | 5,109,000,000 | 5,379,000,000 | 5,071,000,000 | 4,930,000,000 | 251,407,000 | 5,843,000,000 | 5,585,000,000 | 4,095,000,000 | 148,999,000 | 3,928,000,000 | 4,150,000,000 | 3,725,000,000 | 150,105,000 | 4,224,000,000 | 4,354,000,000 | 4,561,000,000 | 97,285,000 | 4,139,000,000 | 4,337,000,000 | 3,767,000,000 | 4,034,000,000 | 4,547,000,000 | 4,430,000,000 | 4,268,000,000 | 4,308,000,000 | 4,093,000,000 | 3,774,000,000 | 3,734,000,000 | 3,577,000,000 | 3,145,000,000 | 3,384,000,000 | 3,336,000,000 | 2,928,000,000 | 1,769,000,000 | 1,658,000,000 | 1,549,000,000 | 1,763,000,000 | 1,829,000,000 | 1,872,000,000 | 1,840,000,000 | 1,679,000,000 | 1,662,000,000 | 1,657,000,000 | 1,725,000,000 | 1,696,000,000 | 1,558,000,000 | 1,579,000,000 | 1,783,000,000 | 1,772,000,000 | 1,705,000,000 | 1,835,000,000 | 1,975,000,000 | 1,973,000,000 | 1,873,000,000 | 1,873,000,000 | 1,843,000,000 | 1,833,000,000 | 1,907,000,000 | 1,783,000,000 | 1,809,000,000 | 1,995,000,000 | 1,989,000,000 | 1,866,000,000 | 2,101,000,000 | 2,073,000,000 | 2,373,000,000 | 2,284,000,000 | 2,300,000,000 | |||||
long-term debt | 13,128,000,000 | 13,092,000,000 | 13,102,000,000 | 13,091,000,000 | 13,082,000,000 | 13,081,000,000 | 12,776,000,000 | 12,769,000,000 | 12,772,000,000 | 14,882,000,000 | 14,901,000,000 | 14,907,000,000 | 14,935,000,000 | 14,934,000,000 | 14,962,000,000 | 14,947,000,000 | 14,719,000,000 | 15,511,000,000 | 14,009,000,000 | 15,091,000,000 | 15,098,000,000 | 15,561,000,000 | 15,728,000,000 | 15,082,000,000 | 14,858,000,000 | 14,312,000,000 | 14,814,000,000 | 14,178,000,000 | 14,204,000,000 | 14,223,000,000 | 14,741,000,000 | 15,012,000,000 | 15,071,000,000 | 15,064,000,000 | 14,323,000,000 | 14,320,000,000 | 14,350,000,000 | 14,383,000,000 | 14,642,000,000 | 14,637,000,000 | 11,824,000,000 | 11,695,000,000 | 11,455,000,000 | 10,942,000,000 | 10,612,000,000 | 10,690,000,000 | 5,690,000,000 | 5,564,000,000 | 5,375,000,000 | 5,158,000,000 | 4,508,000,000 | 4,511,000,000 | 4,295,000,000 | 4,294,000 | 3,966,000,000 | 3,989,000,000 | 4,014,000,000 | 3,997,000,000 | 4,057,000,000 | 4,272,000,000 | 4,271,000,000 | 4,272,000,000 | 4,267,000,000 | 4,624,000,000 | 4,639,000,000 | 4,777,000,000 | 4,775,000,000 | 4,773,000,000 | 4,771,000 | 4,766,000,000 | 4,764,000,000 | 4,762,000,000 | 4,759,000,000 | 4,787,000,000 | 4,785,000,000 | 4,783,000,000 | 4,784,000,000 | 4,782,000,000 | 4,487,000,000 | 4,488,000,000 | 4,032,000,000 | 4,026,000,000 | 4,024,000,000 | |||||||
defined benefit plan obligations | 243,000,000 | 245,000,000 | 296,000,000 | 297,000,000 | 297,000,000 | 298,000,000 | 308,000,000 | 334,000,000 | 334,000,000 | 335,000,000 | 327,000,000 | 329,000,000 | 330,000,000 | 331,000,000 | 400,000,000 | 407,000,000 | 414,000,000 | 421,000,000 | 444,000,000 | 459,000,000 | 478,000,000 | 525,000,000 | 541,000,000 | 547,000,000 | 495,000,000 | 507,000,000 | 512,000,000 | 476,000,000 | 515,000,000 | 528,000,000 | 596,000,000 | 618,000,000 | 624,000,000 | 626,000,000 | 586,000,000 | 594,000,000 | 593,000,000 | 595,000,000 | 621,000,000 | 627,000,000 | 629,000,000 | 633,000,000 | 381,000,000 | 380,000,000 | 395,000,000 | 398,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
other long-term liabilities | 1,693,000,000 | 1,713,000,000 | 1,600,000,000 | 1,635,000,000 | 1,651,000,000 | 1,573,000,000 | 1,560,000,000 | 1,711,000,000 | 1,689,000,000 | 1,709,000,000 | 1,684,000,000 | 1,732,000,000 | 1,748,000,000 | 1,787,000,000 | 1,810,000,000 | 1,824,000,000 | 1,582,000,000 | 1,439,000,000 | 1,592,000,000 | 1,579,000,000 | 1,593,000,000 | 1,564,000,000 | 1,526,000,000 | 1,405,000,000 | 1,405,000,000 | 1,354,000,000 | 1,268,000,000 | 622,000,000 | 599,000,000 | 627,000,000 | 604,000,000 | 598,000,000 | 621,000,000 | 610,000,000 | 606,000,000 | 582,000,000 | 625,000,000 | 594,000,000 | 551,000,000 | 553,000,000 | 534,000,000 | 558,000,000 | 544,000,000 | 484,000,000 | 453,000,000 | 446,000,000 | 620,000,000 | 608,000,000 | 611,000,000 | 595,000,000 | 524,000,000 | 519,000,000 | 526,000,000 | 502,000,000 | 503,000,000 | 550,000,000 | 554,000,000 | 571,000,000 | 572,000,000 | 561,000,000 | 568,000,000 | 562,000,000 | 618,000,000 | 598,000,000 | ||||||||||||||||||||||||||
total liabilities | 22,353,000,000 | 20,704,000,000 | 20,718,000,000 | 20,397,000,000 | 20,584,000,000 | 20,389,000,000 | 21,297,000,000 | 21,396,000,000 | 21,236,000,000 | 22,804,000,000 | 22,409,000,000 | 22,156,000,000 | 22,262,000,000 | 22,548,000,000 | 22,501,000,000 | 22,510,000,000 | 22,236,000,000 | 23,322,000,000 | 22,230,000,000 | 23,362,000,000 | 23,546,000,000 | 631,364,000 | 24,186,000,000 | 24,056,000,000 | 21,794,000,000 | 329,009,000 | 21,393,000,000 | 21,028,000,000 | 21,045,000,000 | 341,492,000 | 20,163,000,000 | 20,338,000,000 | 20,626,000,000 | 245,394,000 | 20,697,000,000 | 21,505,000,000 | 20,986,000,000 | 21,226,000,000 | 21,002,000,000 | 20,813,000,000 | 20,459,000,000 | 20,458,000,000 | 20,473,000,000 | 20,137,000,000 | 17,245,000,000 | 16,955,000,000 | 16,050,000,000 | 15,757,000,000 | 15,363,000,000 | 15,005,000,000 | 8,334,000,000 | 8,095,000,000 | 7,833,000,000 | 7,810,000,000 | 7,185,000,000 | 7,240,000,000 | 6,998,000,000 | 6,516,000,000 | 6,545,000,000 | 6,616,000,000 | 6,681,000,000 | 6,771,000,000 | 7,008,000,000 | 7,024,000,000 | 7,256,000,000 | 7,203,000,000 | 7,595,000,000 | 7,754,000,000 | 8,158,000,000 | 8,214,000,000 | 8,142,000,000 | 8,134,000,000 | 8,104,000,000 | 8,108,000,000 | 8,411,000,000 | 8,493,000,000 | 8,238,000,000 | 8,604,000,000 | 8,504,000,000 | 8,458,000,000 | 8,277,000,000 | |||||||||
commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
redeemable noncontrolling interests in equity of consolidated subsidiaries | 2,137,000,000 | 2,956,000,000 | 2,917,000,000 | 2,826,000,000 | 2,776,000,000 | 2,727,000,000 | 2,649,000,000 | 2,813,000,000 | 2,728,000,000 | 2,391,000,000 | 2,303,000,000 | 2,277,000,000 | 2,225,000,000 | 2,149,000,000 | 2,068,000,000 | 1,997,000,000 | 2,358,000,000 | 2,203,000,000 | 2,048,000,000 | 2,034,000,000 | 1,992,000,000 | 1,479,000,000 | 1,561,000,000 | 1,526,000,000 | 1,475,000,000 | 1,462,000,000 | 1,439,000,000 | 1,444,000,000 | 1,429,000,000 | 1,942,000,000 | 1,816,000,000 | 1,781,000,000 | 2,430,000,000 | 2,393,000,000 | 2,307,000,000 | 2,275,000,000 | 2,381,000,000 | 2,266,000,000 | 1,682,000,000 | 1,591,000,000 | 208,000,000 | 401,000,000 | 396,000,000 | 277,000,000 | 267,000,000 | 247,000,000 | 83,000,000 | 80,000,000 | 36,000,000 | 16,000,000 | 16,000,000 | 16,000,000 | 16,000,000 | 16,000,000 | 16,000,000 | |||||||||||||||||||||||||||||||||||
equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders’ equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 27,000,000 | 27,000,000 | 27,000,000 | 27,000,000 | 27,000,000 | 27,000,000 | 27,000,000 | 27,000,000 | 27,000,000 | 27,000,000 | 26,000,000 | 26,000,000 | 26,000,000 | 26,000,000 | 26,000,000 | 27,000,000 | 26,000,000 | 26,000,000 | 26,000,000 | 26,000,000 | 26,000,000 | 26,000,000 | 26,000,000 | 26,000,000 | 26,000,000 | 4,260,000,000 | 4,230,000,000 | 4,112,000,000 | 4,066,000,000 | 3,519,000,000 | |||||||||
additional paid-in capital | 5,124,000,000 | 4,914,000,000 | 4,872,000,000 | 4,858,000,000 | 4,826,000,000 | 4,873,000,000 | 4,849,000,000 | 4,840,000,000 | 4,806,000,000 | 4,834,000,000 | 4,818,000,000 | 4,800,000,000 | 4,774,000,000 | 4,778,000,000 | 4,771,000,000 | 4,756,000,000 | 4,765,000,000 | 4,877,000,000 | 4,862,000,000 | 4,854,000,000 | 4,841,000,000 | 4,826,000,000 | 4,751,000,000 | 4,739,000,000 | 4,751,000,000 | 4,755,000,000 | 4,748,000,000 | 4,733,000,000 | 4,722,000,000 | 4,833,000,000 | 4,835,000,000 | 4,819,000,000 | 4,834,000,000 | 4,827,000,000 | 4,801,000,000 | 4,791,000,000 | 4,804,000,000 | 4,815,000,000 | 4,798,000,000 | 4,774,000,000 | 4,751,000,000 | 4,614,000,000 | 4,597,000,000 | 4,594,000,000 | 4,576,000,000 | 4,572,000,000 | 4,562,000,000 | 4,552,000,000 | 4,484,000,000 | 4,471,000,000 | 4,437,000,000 | 4,410,000,000 | 4,403,000,000 | 4,425,000,000 | 4,425,000,000 | 4,448,000,000 | 4,449,000,000 | 4,461,000,000 | 4,461,000,000 | 4,459,000,000 | 4,461,000,000 | 4,464,000,000 | 4,457,000,000 | 4,450,000,000 | 4,437,000,000 | 4,431,000,000 | 4,420,000,000 | 4,401,000,000 | 4,391,000,000 | 4,379,000,000 | 4,347,000,000 | 4,335,000,000 | 4,329,000,000 | 4,191,000,000 | 4,174,000,000 | 4,158,000,000 | ||||||||||||||
accumulated other comprehensive loss | -179,000,000 | -181,000,000 | -174,000,000 | -177,000,000 | -178,000,000 | -180,000,000 | -175,000,000 | -177,000,000 | -179,000,000 | -181,000,000 | -176,000,000 | -178,000,000 | -179,000,000 | -181,000,000 | -229,000,000 | -231,000,000 | -233,000,000 | -233,000,000 | -274,000,000 | -277,000,000 | -282,000,000 | -251,000,000 | -255,000,000 | -256,000,000 | -216,000,000 | -219,000,000 | -221,000,000 | -202,000,000 | -243,000,000 | -239,000,000 | -238,000,000 | -242,000,000 | -255,000,000 | -258,000,000 | -200,000,000 | -203,000,000 | -160,000,000 | -164,000,000 | -173,000,000 | -177,000,000 | -179,000,000 | -182,000,000 | -20,000,000 | -43,000,000 | -43,000,000 | -43,000,000 | -43,000,000 | -30,000,000 | -31,000,000 | -31,000,000 | -32,000,000 | -27,000,000 | -31,000,000 | -34,000,000 | -29,000,000 | -26,000,000 | -28,000,000 | |||||||||||||||||||||||||||||||||
retained earnings | 5,117,000,000 | 4,415,000,000 | 4,044,000,000 | 3,702,000,000 | 3,414,000,000 | 3,008,000,000 | 2,690,000,000 | 2,218,000,000 | 1,959,000,000 | 1,092,000,000 | 1,162,000,000 | 2,662,000,000 | 2,970,000,000 | 3,653,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 73,005 shares at march 31, 2026 and 71,660 shares at december 31, 2025 | -5,256,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total shareholders’ equity | 4,814,000,000 | 4,220,000,000 | 4,014,000,000 | 3,749,000,000 | 4,181,000,000 | 4,171,000,000 | 3,834,000,000 | 3,475,000,000 | 3,453,000,000 | 1,608,000,000 | 1,464,000,000 | 1,343,000,000 | 1,233,000,000 | 1,142,000,000 | 1,235,000,000 | 1,087,000,000 | 1,056,000,000 | 1,028,000,000 | 722,000,000 | 261,000,000 | 123,000,000 | -154,000,000 | -65,000,000 | 24,000,000 | 373,000,000 | 430,000,000 | 417,000,000 | 528,000,000 | 523,000,000 | 625,000,000 | 691,000,000 | 802,000,000 | 803,000,000 | 839,000,000 | 651,000,000 | 735,000,000 | 723,000,000 | 728,000,000 | 755,000,000 | 825,000,000 | 895,000,000 | 969,000,000 | 1,143,000,000 | 1,224,000,000 | 1,176,000,000 | 1,460,000,000 | 1,698,000,000 | 1,810,000,000 | 1,844,000,000 | 1,766,000,000 | 1,711,000,000 | 772,000,000 | 739,000,000 | 646,000,000 | 626,000,000 | 286,000,000 | 291,000,000 | 136,000,000 | 29,000,000 | 32,000,000 | 101,000,000 | 149,000,000 | 167,000,000 | 631,000,000 | 707,000,000 | 1,099,000,000 | 1,363,000,000 | 1,755,000,000 | 1,757,000,000 | 3,849,000,000 | 3,887,000,000 | 5,272,000,000 | 5,531,000,000 | 5,762,000,000 | ||||||||||||||||
noncontrolling interests | 1,899,000,000 | 1,797,000,000 | 1,769,000,000 | 1,727,000,000 | 1,696,000,000 | 1,649,000,000 | 1,592,000,000 | 1,581,000,000 | 1,490,000,000 | 1,509,000,000 | 1,414,000,000 | 1,381,000,000 | 1,347,000,000 | 1,317,000,000 | 1,272,000,000 | 1,027,000,000 | 1,000,000,000 | 1,026,000,000 | 913,000,000 | 908,000,000 | 893,000,000 | 896,000,000 | 890,000,000 | 861,000,000 | 830,000,000 | 825,000,000 | 808,000,000 | 766,000,000 | 730,000,000 | 681,000,000 | 671,000,000 | 682,000,000 | 664,000,000 | 665,000,000 | 637,000,000 | 629,000,000 | 301,000,000 | 267,000,000 | 216,000,000 | 215,000,000 | 133,000,000 | 134,000,000 | 131,000,000 | 150,000,000 | 126,000,000 | 123,000,000 | 95,000,000 | 86,000,000 | 77,000,000 | 75,000,000 | 45,000,000 | 53,000,000 | 71,000,000 | 63,000,000 | 64,000,000 | 64,000,000 | 53,000,000 | 53,000,000 | 54,000,000 | 52,000,000 | 51,000,000 | 47,000,000 | 47,000,000 | 47,000,000 | ||||||||||||||||||||||||||
total equity | 6,713,000,000 | 6,017,000,000 | 5,783,000,000 | 5,476,000,000 | 5,877,000,000 | 5,820,000,000 | 5,426,000,000 | 5,056,000,000 | 4,943,000,000 | 3,117,000,000 | 2,878,000,000 | 2,724,000,000 | 2,580,000,000 | 2,459,000,000 | 2,507,000,000 | 2,114,000,000 | 2,056,000,000 | 2,054,000,000 | 1,635,000,000 | 1,169,000,000 | 1,016,000,000 | 551,476,000 | 522,000,000 | 633,000,000 | 503,000,000 | 452,722,000 | 489,000,000 | 717,000,000 | 674,000,000 | 453,383,000 | 658,000,000 | 576,000,000 | 616,000,000 | 288,366,000 | 695,000,000 | 1,055,000,000 | 1,094,000,000 | 1,082,000,000 | 1,165,000,000 | 1,152,000,000 | 926,000,000 | 958,000,000 | 1,018,000,000 | 1,018,000,000 | 972,000,000 | 785,000,000 | 866,000,000 | 873,000,000 | 854,000,000 | 878,000,000 | 920,000,000 | 981,000,000 | 1,046,000,000 | 1,218,000,000 | 1,269,000,000 | 1,229,000,000 | 1,531,000,000 | 1,492,000 | 1,761,000,000 | 1,874,000,000 | 1,908,000,000 | 1,819,000,000 | 1,764,000,000 | 826,000,000 | 791,000,000 | 697,000,000 | 673,000,000 | 333,000,000 | 338,000,000 | |||||||||||||||||||||
total liabilities and equity | 31,203,000,000 | 29,677,000,000 | 29,418,000,000 | 28,699,000,000 | 29,237,000,000 | 28,936,000,000 | 29,372,000,000 | 29,265,000,000 | 28,907,000,000 | 28,312,000,000 | 27,590,000,000 | 27,157,000,000 | 27,067,000,000 | 27,156,000,000 | 27,076,000,000 | 26,621,000,000 | 26,650,000,000 | 27,579,000,000 | 25,913,000,000 | 26,565,000,000 | 26,554,000,000 | 1,388,800,000 | 26,187,000,000 | 26,250,000,000 | 23,823,000,000 | 952,371,000 | 23,357,000,000 | 23,207,000,000 | 23,158,000,000 | 967,291,000 | 22,265,000,000 | 22,343,000,000 | 23,184,000,000 | 642,907,000 | 23,208,000,000 | 24,341,000,000 | 24,510,000,000 | 24,701,000,000 | 24,474,000,000 | 24,240,000,000 | 23,766,000,000 | 23,682,000,000 | 23,173,000,000 | 22,746,000,000 | 18,425,000,000 | 18,141,000,000 | 17,312,000,000 | 16,907,000,000 | 16,484,000,000 | 16,130,000,000 | 9,337,000,000 | 9,156,000,000 | 8,915,000,000 | 9,044,000,000 | 8,470,000,000 | 8,485,000,000 | 8,545,000,000 | 8,293,000,000 | 8,435,000,000 | 8,524,000,000 | 8,500,000,000 | 8,535,000,000 | 7,834,000,000 | 7,815,000,000 | 7,953,000,000 | 7,876,000,000 | 7,928,000,000 | 8,092,000,000 | ||||||||||||||||||||||
liabilities held for sale | 12,000,000 | 12,000,000 | 12,000,000 | 13,000,000 | 12,000,000 | 11,000,000 | 11,000,000 | 69,000,000 | 17,000,000 | 17,000,000 | 23,000,000 | 145,000,000 | 68,000,000 | 91,000,000 | 93,000,000 | 49,000,000 | 71,000,000 | 393,000,000 | 406,000,000 | 407,000,000 | 51,000,000 | 9,000,000 | 13,000,000 | 101,000,000 | 226,000,000 | 244,000,000 | 45,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 71,660 shares at december 31, 2025 and 62,892 shares at december 31, 2024 | -4,936,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 70,718 shares at september 30, 2025 and 62,892 shares at december 31, 2024 | -4,736,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 70,121 shares at june 30, 2025 and 62,892 shares at december 31, 2024 | -4,642,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 65,520 shares at march 31, 2025 and 62,892 shares at december 31, 2024 | -3,889,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 62,892 shares at december 31, 2024 and 57,321 shares at december 31, 2023 | -3,538,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 62,899 shares at september 30, 2024 and 57,321 shares at december 31, 2023 | -3,538,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 62,111 shares at june 30, 2024 and 57,321 shares at december 31, 2023 | -3,414,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 60,132 shares at march 31, 2024 and 57,321 shares at december 31, 2023 | -3,141,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated deficit | -192,000,000 | -436,000,000 | -537,000,000 | -660,000,000 | -803,000,000 | -905,000,000 | -1,036,000,000 | -1,074,000,000 | -1,214,000,000 | -1,463,000,000 | -1,912,000,000 | -2,031,000,000 | -2,542,000,000 | -2,346,000,000 | -2,434,000,000 | -2,469,000,000 | -2,237,000,000 | -2,254,000,000 | -2,231,000,000 | -2,222,000,000 | -2,248,000,000 | -2,161,000,000 | -1,794,000,000 | -1,739,000,000 | -1,742,000,000 | -1,663,000,000 | -1,655,000,000 | -1,609,000,000 | -1,550,000,000 | -1,453,000,000 | -1,424,000,000 | -1,363,000,000 | -1,410,000,000 | -1,471,000,000 | -1,370,000,000 | -1,382,000,000 | -1,443,000,000 | -1,522,000,000 | -1,602,000,000 | -2,540,000,000 | -2,571,000,000 | -2,665,000,000 | -2,692,000,000 | -2,689,000,000 | -2,674,000,000 | -2,819,000,000 | -2,923,000,000 | -2,908,000,000 | ||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 57,321 shares at december 31, 2023 and 54,215 shares at december 31, 2022 | -2,861,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract liabilities | 86,000,000 | 76,000,000 | 76,000,000 | 110,000,000 | 111,000,000 | 474,000,000 | 776,000,000 | 959,000,000 | 1,218,000,000 | 1,055,000,000 | 917,000,000 | 77,239,000 | 1,500,000,000 | 1,496,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 55,695 shares at september 30, 2023 and 54,216 shares at december 31, 2022 | -2,750,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 55,696,591 shares at june 30, 2023 and 54,215,871 shares at december 31, 2022 | -2,750,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 55,120,211 shares at march 31, 2023 and 54,215,871 shares at december 31, 2022 | -2,710,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract liabilities – long-term | 13,000,000 | 14,000,000 | 14,000,000 | 14,000,000 | 15,000,000 | 15,000,000 | 351,000,000 | 655,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 54,215,871 shares at december 31, 2022 and 48,331,649 shares at december 31, 2021 | -2,660,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax receivable | 4,000,000 | 18,000,000 | 2,000,000 | 18,000,000 | 18,000,000 | 18,000,000 | 19,000,000 | 17,000,000 | 27,000,000 | 28,000,000 | 20,000,000 | 14,000,000 | 7,000,000 | 26,000,000 | 4,000,000 | 11,000,000 | 3,000,000 | 7,000,000 | 33,000,000 | 27,000,000 | 2,000,000 | 2,000,000 | 22,000,000 | 34,000,000 | 19,000,000 | 3,000,000 | 12,000,000 | 4,000,000 | 7,000,000 | 13,000,000 | 13,000,000 | 5,000,000 | 7,000,000 | 1,000,000 | 22,000,000 | 22,000,000 | 21,000,000 | 13,000,000 | 26,000,000 | 35,000,000 | 5,000,000 | 20,000,000 | 29,000,000 | 7,000,000 | 5,000,000 | 3,000,000 | 173,000,000 | 174,000,000 | 172,000,000 | 149,000,000 | 95,000,000 | |||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,327,503 shares at september 30, 2022 and 48,331,649 shares at december 31, 2021 | -2,410,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,330,239 shares at june 30, 2022 and 48,331,649 shares at december 31, 2021 | -2,410,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,331,319 shares at march 31, 2022 and 48,331,649 shares at december 31, 2021 | -2,410,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,331,649 shares at december 31, 2021 and 48,337,947 shares at december 31, 2020 | -2,410,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,333,196 shares at september 30, 2021 and 48,337,947 shares at december 31, 2020 | -2,411,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,334,331 shares at june 30, 2021 and 48,337,947 shares at december 31, 2020 | -2,412,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,334,419 shares at march 31, 2021 and 48,337,947 shares at december 31, 2020 | -2,413,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash | 52,739,000 | 23,703,000 | 29,041,000 | 19,957,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
funds due from uspi | 288,180,000 | 101,282,000 | 114,408,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient receivables | 111,452,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplies | 27,720,000 | 27,017,000 | 26,070,000 | 20,568,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid and other current assets | 7,983,000 | 13,951,000 | 8,533,000 | 5,277,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
property and equipment | 214,493,000 | 234,423,000 | 238,054,000 | 154,768,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating lease assets | 245,225,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash | 1,455,000 | 1,300,000 | 4,439,000 | 9,960,000 | 263,000,000 | 263,000,000 | 263,000,000 | 263,000,000 | 263,000,000 | 263,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investments in unconsolidated affiliates | 7,531,000 | 6,837,000 | 6,987,000 | 7,143,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
goodwill and intangible assets | 431,797,000 | 432,000,000 | 431,828,000 | 259,332,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other | 225,000 | 279,000 | 505,000 | 217,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable, including funds due to uspi of 9,860 and 10,747 at june 30, 2020 and 2019, respectively | 68,696,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued expenses and other current liabilities | 51,643,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current maturities of long-term obligations | 21,372,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of operating lease liabilities | 32,457,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-current liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term obligations, net of current portion | 144,808,000 | 161,930,000 | 174,228,000 | 134,604,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term operating lease liabilities, less current portion | 230,969,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other liabilities | 4,180,000 | 18,080,000 | 17,159,000 | 13,505,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
noncontrolling interests - redeemable | 205,960,000 | 170,640,000 | 172,416,000 | 109,147,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
members' equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
members’ equity | 515,678,000 | 419,847,000 | 419,870,000 | 263,758,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
noncontrolling interests – nonredeemable | 35,798,000 | 32,875,000 | 33,513,000 | 24,608,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,337,999 shares at september 30, 2020 and 48,344,195 shares at december 31, 2019 | -2,414,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total shareholders’ deficit | -374,000,000 | -257,000,000 | -358,000,000 | -341,000,000 | -108,000,000 | -134,000,000 | -108,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,341,041 shares at june 30, 2020 and 48,344,195 shares at december 31, 2019 | -2,414,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,342,502 shares at march 31, 2020 and 48,344,195 shares at december 31, 2019 | -2,414,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient receivables, net of allowance for doubtful accounts of 60,631 at june 30, 2018 | 111,579,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable, including funds due to uspi of 10,747 and 16,014 at june 30, 2019 and 2018, respectively | 78,658,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued expenses and other | 47,092,000 | 43,163,000 | 32,892,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of long-term obligations | 23,249,000 | 19,789,000 | 18,301,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,346,277 shares at september 30, 2019 and 48,359,705 shares at december 31, 2018 | -2,414,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,348,348 shares at june 30, 2019 and 48,359,705 shares at december 31, 2018 | -2,414,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,352,853 shares at march 31, 2019 and 48,359,705 shares at december 31, 2018 | -2,414,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient receivables, net of allowance for doubtful accounts of 60,631 and 44,306 at june 30, 2018 and 2017, respectively | 107,426,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable, including funds due to uspi of 16,014 and 11,568 at june 30, 2018 and 2017, respectively | 87,153,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,360,191 shares at september 30, 2018 and 48,413,169 shares at december 31, 2017 | -2,415,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,397,605 shares at june 30, 2018 and 48,413,169 shares at december 31, 2017 | -2,418,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,402,616 shares at march 31, 2018 and 48,413,169 shares at december 31, 2017 | -2,418,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
funds due from united surgical partners, inc. | 82,280,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient receivables, net of allowance for doubtful accounts of 16,102 and 14,952 at june 30, 2017 and 2016, respectively | 83,405,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other long-term assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivables | 2,567,000,000 | 2,706,000,000 | 2,960,000,000 | 2,897,000,000 | 2,786,000,000 | 2,734,000,000 | 2,807,000,000 | 2,704,000,000 | 2,525,000,000 | 2,505,000,000 | 2,468,000,000 | 2,404,000,000 | 2,238,000,000 | 2,171,000,000 | 2,141,000,000 | 2,038,000,000 | 1,380,000,000 | 1,369,000,000 | 1,383,000,000 | 1,345,000,000 | 1,338,000,000 | 1,356,000,000 | 1,417,000,000 | 1,221,000,000 | 1,258,000,000 | 1,237,000,000 | 1,143,000,000 | 1,129,000,000 | 1,160,000,000 | 1,208,000,000 | 1,158,000,000 | 1,195,000,000 | 1,225,000,000 | 1,385,000,000 | 1,356,000,000 | 1,450,000,000 | 1,468,000,000 | 1,354,000,000 | 1,363,000,000 | 1,427,000,000 | 1,453,000,000 | 1,484,000,000 | 1,584,000,000 | 1,523,000,000 | 1,506,000,000 | 1,595,000,000 | 1,791,000,000 | 1,929,000,000 | 2,465,000,000 | 2,667,000,000 | 2,662,000,000 | |||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,413,280 shares at september 30, 2017 and 48,420,650 shares at december 31, 2016 | -2,419,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued legal settlement costs | 1,000,000 | 11,000,000 | 8,000,000 | 527,000,000 | 525,000,000 | 423,000,000 | 294,000,000 | 8,000,000 | 7,000,000 | 7,000,000 | 56,000,000 | 10,000,000 | 10,000,000 | 13,000,000 | 8,000,000 | 8,000,000 | 31,000,000 | 55,000,000 | 76,000,000 | 96,000,000 | 174,000,000 | 168,000,000 | 167,000,000 | 167,000,000 | 167,000,000 | 113,000,000 | 93,000,000 | 88,000,000 | 47,000,000 | 58,000,000 | 90,000,000 | 130,000,000 | 128,000,000 | 45,000,000 | 11,000,000 | 19,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,417,575 shares at june 30, 2017 and 48,420,650 shares at december 31, 2016 | -2,417,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,419,483 shares at march 31, 2017 and 48,420,650 shares at december 31, 2016 | -2,417,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,420,650 shares at december 31, 2016 and 48,425,298 shares at december 31, 2015 | -2,417,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,420,844 shares at september 30, 2016 and 48,425,298 shares at december 31, 2015 | -2,417,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,421,605 shares at june 30, 2016 and 48,425,298 shares at december 31, 2015 | -2,417,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,424,273 shares at march 31, 2016 and 48,425,298 shares at december 31, 2015 | -2,417,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 48,425,298 shares at december 31, 2015 and 47,196,902 shares at december 31, 2014 | -2,417,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of deferred income taxes | 625,000,000 | 637,000,000 | 718,000,000 | 747,000,000 | 725,000,000 | 633,000,000 | 577,000,000 | 581,000,000 | 358,000,000 | 350,000,000 | 354,000,000 | 354,000,000 | 394,000,000 | 409,000,000 | 411,000,000 | 247,000,000 | 249,000,000 | 283,000,000 | 282,000,000 | 307,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income taxes, net of current portion | 82,000,000 | 89,000,000 | 66,000,000 | 116,000,000 | 100,000,000 | 125,000,000 | 129,000,000 | 90,000,000 | 396,000,000 | 420,000,000 | 395,000,000 | 342,000,000 | 338,000,000 | 345,000,000 | 342,000,000 | 533,000,000 | 543,000,000 | 589,000,000 | 627,000,000 | 636,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 47,182,492 shares at september 30, 2015 and 47,196,902 shares at december 31, 2014 | -2,377,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 47,182,990 shares at june 30, 2015 and 47,196,902 shares at december 31, 2014 | -2,377,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term borrowings | 400,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 47,183,241 shares at march 31, 2015 and 47,196,902 shares at december 31, 2014 | -2,377,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 47,196,902 shares at december 31, 2014 and 47,197,722 shares at december 31, 2013 | -2,378,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 47,196,935 shares at september 30, 2014 and 47,197,722 shares at december 31, 2013 | -2,378,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 47,196,972 shares at june 30, 2014 and 47,197,722 shares at december 31, 2013 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 47,197,211 shares at march 31, 2014 and 47,197,722 shares at december 31, 2013 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 47,197,722 shares at december 31, 2013 and 37,730,431 shares at december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 44,807,632 shares at september 30, 2013 and 37,730,431 shares at december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 42,165,478 shares at june 30, 2013 and 37,730,431 shares at december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 40,172,225 shares at march 31, 2013 and 37,730,431 shares at december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at december 31, 2011 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 37,730,431 shares at december 31, 2012 and 34,110,674 shares at december 31, 2011 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 46,300 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at september 30, 2012 and 345,000 at december 31, 2011 | 45,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 34,320,438 shares at september 30, 2012 and 34,110,674 shares at december 31, 2011 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 46,300 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at june 30, 2012 and 345,000 at december 31, 2011 | 45,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 137,295,241 shares at june 30, 2012 and 136,442,696 shares at december 31, 2011 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at both march 31, 2012 and december 31, 2011 | 334,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 138,100,420 shares at march 31, 2012 and 136,442,696 shares at december 31, 2011 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
working capital | 542,000 | 512,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at september 30, 2011 and december 31, 2010 | 334,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 96,253,367 shares at september 30, 2011 and 65,098,918 shares at december 31, 2010 | -1,675,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at june 30, 2011 and december 31, 2010 | 334,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 72,377,607 shares at june 30, 2011 and 65,098,918 shares at december 31, 2010 | -1,551,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investments in reserve yield plus fund | 2,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 2,000,000 | 3,000,000 | 6,000,000 | 6,000,000 | 48,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investments in marketable securities | 1,000,000 | 1,000,000 | 1,000,000 | 2,000,000 | 11,000,000 | 16,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at march 31, 2011 and december 31, 2010 | 334,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock in treasury, at cost, 61,655,445 shares at march 31, 2011 and 65,098,918 shares at december 31, 2010 | -1,479,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at both december 31, 2010 and 2009 | 334,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 65,098,918 shares at december 31, 2010 and 57,475,602 shares at december 31, 2009 | -1,479,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at september 30, 2010 and december 31, 2009 | 334,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost; 65,383,026 shares at september 30, 2010 and 57,475,602 shares at december 31, 2009 | -1,479,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at june 30, 2010 and december 31, 2009 | 334,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost; 65,507,033 shares at june 30, 2010 and 57,475,602 shares at december 31, 2009 | -1,479,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at march 31, 2010 and december 31, 2009 | 334,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 66,043,509 shares at march 31, 2010 and 57,475,602 shares at december 31, 2009 | -1,479,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at december 31, 2009 and 0 shares issued at december 31, 2008 | 334,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 57,475,602 shares at december 31, 2009 and 55,716,859 shares at december 31, 2008 | -1,479,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.15 par value; authorized 2,500,000 shares; 345,000 of 7% mandatory convertible shares with a liquidation preference of 1,000 per share issued at september 30, 2009 and 0 shares issued at december 31, 2008 | 334,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 57,510,881 shares at september 30, 2009 and 55,716,859 shares at december 31, 2008 | -1,479,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investments in marketable debt securities | 3,000,000 | 1,000,000 | 8,000,000 | 14,000,000 | 34,000,000 | 39,000,000 | 38,000,000 | 15,000,000 | 11,000,000 | 10,000,000 | 65,000,000 | 75,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 54,722,347 shares at june 30, 2009 and 55,716,859 shares at december 31, 2008 | -1,477,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 54,828,608 shares at march 31, 2009 and 55,716,859 shares at december 31, 2008 | -1,477,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
fixed-rate long-term debt | 1,001,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
average interest rates | 7,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and shareholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other long-term liabilities and minority interests | 649,000,000 | 654,000,000 | 664,000,000 | 646,000,000 | 631,000,000 | 618,000,000 | 726,000,000 | 914,000,000 | 918,000,000 | 873,000,000 | 858,000,000 | 917,000,000 | 980,000,000 | 991,000,000 | 1,548,000,000 | 1,503,000,000 | 1,298,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 55,716,859 shares at december 31, 2008 and 56,310,604 shares at december 31, 2007 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and shareholders’ equity | 8,294,000,000 | 8,243,000,000 | 8,174,000,000 | 8,235,000,000 | 8,253,000,000 | 8,275,000,000 | 9,042,000,000 | 9,200,000,000 | 9,337,000,000 | 9,967,000,000 | 10,259,000,000 | 12,126,000,000 | 12,150,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 55,741,855 shares at september 30, 2008 and 56,310,604 shares at december 31, 2007 | -1,479,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 56,089,373 shares at june 30, 2008 and 56,310,604 shares at december 31, 2007 | -1,479,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 55,538,298 shares at march 31, 2008 and 56,310,604 shares at december 31, 2007 | -1,479,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders’ equity | 54,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 56,301,997 shares at september 30, 2007 and 55,798,815 shares at december 31, 2006 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 56,811,675 shares at june 30, 2007 and 55,798,815 shares at december 31, 2006 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 56,484,035 shares at march 31, 2007 and 55,798,815 shares at december 31, 2006 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
receivable for insurance recoveries | 285,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes payable | 107,000,000 | 1,000,000 | 36,000,000 | 89,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 55,739,750 shares at september 30, 2006 and 55,663,588 shares at december 31, 2005 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 56,206,714 shares at june 30, 2006 and 55,663,588 shares at december 31, 2005 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 55,548,334 shares at march 31, 2006 and 55,663,588 shares at december 31, 2005 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and shareholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
shareholders' equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and shareholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
professional liability reserves | 145,000,000 | 145,000,000 | 134,000,000 | 108,000,000 | 116,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 55,555,441 shares at september 30, 2005 and 53,896,498 shares at december 31, 2004 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 55,684,146 shares at june 30, 2005 and 53,896,498 shares at december 31, 2004 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investments in debt securities | 112,000,000 | 122,000,000 | 123,000,000 | 103,000,000 | 103,000,000 | 97,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 54,102,719 shares at march 31, 2005 and 53,896,498 shares at december 31, 2004 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
property and equipment, at lower of cost or fair value, less accumulated depreciation and amortization | 4,837,000,000 | 4,823,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other intangible assets, at lower of cost or fair value, less accumulated amortization | 181,000,000 | 181,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued interest | 89,000,000 | 50,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 54,226,419 shares at december 31 and 54,171,584 shares at september 30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 54,226,419 shares at december 31 and 54,193,619 shares at june 30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
property and equipment, at cost less accumulated depreciation and amortization | 5,914,000,000 | 5,899,000,000 | 6,412,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued litigation settlement costs | 253,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 41,895,162 shares at december 31 and 54,227,639 shares at september 30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 41,895,162 shares at december 31 and 54,366,661 shares at june 30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less common stock in treasury, at cost, 23,812,812 shares at may 31 and 47,895,162 shares at february 28 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-03-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-09-30 | 2003-02-28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 906,000,000 | 644,000,000 | 579,000,000 | 522,000,000 | 622,000,000 | 572,000,000 | 681,000,000 | 477,000,000 | 2,334,000,000 | 456,000,000 | 266,000,000 | 293,000,000 | 296,000,000 | 274,000,000 | 268,000,000 | 179,000,000 | 280,000,000 | 419,000,000 | 578,000,000 | 257,000,000 | 222,000,000 | 111,931,000 | -106,000,000 | 169,000,000 | 159,000,000 | 264,449,000 | -152,000,000 | 112,000,000 | 65,000,000 | -66,735,000 | 65,000,000 | 108,000,000 | 191,000,000 | 488,815,000 | -289,000,000 | 23,000,000 | 80,000,000 | 39,000,000 | 34,000,000 | 2,000,000 | 28,000,000 | -28,000,000 | 76,000,000 | -7,000,000 | -16,000,000 | -14,000,000 | 36,000,000 | -43,000,000 | -83,000,000 | 54,000,000 | 32,000,000 | -20,000,000 | 67,000,000 | -66,000,000 | 15,000,000 | 63,000,000 | 82,000,000 | 82,000,000 | 940,000,000 | 35,000,000 | 95,000,000 | 29,000,000 | -1,000,000 | -14,000,000 | 183,000,000 | -33,000,000 | 104,000,000 | -15,000,000 | -31,000,000 | -75,000,000 | -59,000,000 | -30,000,000 | 75,000,000 | 70,000,000 | -408,000,000 | -21,000,000 | -3,000,000 | 598,000,000 | |||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 229,000,000 | 231,000,000 | 218,000,000 | 208,000,000 | 206,000,000 | 193,000,000 | 209,000,000 | 208,000,000 | 208,000,000 | 216,000,000 | 224,000,000 | 213,000,000 | 217,000,000 | 213,000,000 | 209,000,000 | 216,000,000 | 203,000,000 | 201,000,000 | 209,000,000 | 221,000,000 | 224,000,000 | -583,714,000 | 215,000,000 | 206,000,000 | 203,000,000 | -587,038,000 | 205,000,000 | 214,000,000 | 208,000,000 | -570,171,000 | 204,000,000 | 194,000,000 | 204,000,000 | -634,265,000 | 219,000,000 | 218,000,000 | 205,000,000 | 215,000,000 | 212,000,000 | 208,000,000 | 185,000,000 | 197,000,000 | 207,000,000 | 240,000,000 | 207,000,000 | 209,000,000 | 193,000,000 | 191,000,000 | 119,000,000 | 121,000,000 | 114,000,000 | 116,000,000 | 110,000,000 | 100,000,000 | 104,000,000 | 105,000,000 | 103,000,000 | 104,000,000 | 101,000,000 | 101,000,000 | 101,000,000 | 97,000,000 | 95,000,000 | 95,000,000 | 97,000,000 | 97,000,000 | 97,000,000 | 96,000,000 | 90,000,000 | 92,000,000 | 95,000,000 | 93,000,000 | 91,000,000 | 89,000,000 | 89,000,000 | 90,000,000 | 105,000,000 | 92,000,000 | 96,000,000 | 98,000,000 | 390,000,000 |
deferred income tax expense | -40,000,000 | -42,000,000 | 40,000,000 | 7,000,000 | 4,000,000 | -74,000,000 | 64,000,000 | -55,000,000 | -38,000,000 | -23,000,000 | 38,000,000 | 29,000,000 | 8,000,000 | 1,000,000 | 76,000,000 | 69,000,000 | 63,000,000 | 67,000,000 | 135,000,000 | 24,000,000 | 24,000,000 | -197,000,000 | 30,000,000 | -79,000,000 | 15,000,000 | 23,000,000 | 19,000,000 | 2,000,000 | 38,000,000 | 70,000,000 | -64,000,000 | 9,000,000 | -5,000,000 | 6,000,000 | 31,000,000 | 12,000,000 | 34,000,000 | 21,000,000 | -1,000,000 | 38,000,000 | 56,000,000 | 35,000,000 | 32,000,000 | -996,000,000 | 7,000,000 | 5,000,000 | 3,000,000 | 6,000,000 | 8,000,000 | 3,000,000 | -5,000,000 | -5,000,000 | 21,000,000 | ||||||||||||||||||||||||||||
stock-based compensation expense | 25,000,000 | 25,000,000 | 38,000,000 | 20,000,000 | 21,000,000 | 15,000,000 | 16,000,000 | 19,000,000 | 17,000,000 | 18,000,000 | 15,000,000 | 19,000,000 | 14,000,000 | 9,000,000 | 13,000,000 | 18,000,000 | 16,000,000 | 13,000,000 | 13,000,000 | 16,000,000 | 14,000,000 | 11,000,000 | 14,000,000 | 13,000,000 | 11,000,000 | 12,000,000 | 11,000,000 | 14,000,000 | 11,000,000 | 9,000,000 | 15,000,000 | 17,000,000 | 16,000,000 | 19,000,000 | 16,000,000 | 19,000,000 | 17,000,000 | 18,000,000 | 15,000,000 | 10,000,000 | 15,000,000 | 14,000,000 | 12,000,000 | 10,000,000 | 7,000,000 | 8,000,000 | 11,000,000 | 8,000,000 | 7,000,000 | 9,000,000 | 8,000,000 | 7,000,000 | 5,000,000 | 5,000,000 | 7,000,000 | 4,000,000 | 5,000,000 | 6,000,000 | 7,000,000 | 5,000,000 | 5,000,000 | 6,000,000 | 7,000,000 | 6,000,000 | 7,000,000 | 10,000,000 | 10,000,000 | ||||||||||||||
impairment and restructuring charges, and acquisition-related costs | 24,000,000 | 64,000,000 | 23,000,000 | 24,000,000 | 19,000,000 | 27,000,000 | 19,000,000 | 29,000,000 | 27,000,000 | 53,000,000 | 47,000,000 | 16,000,000 | 21,000,000 | 129,000,000 | 24,000,000 | 57,000,000 | 16,000,000 | 30,000,000 | 15,000,000 | 20,000,000 | 20,000,000 | 57,000,000 | 54,000,000 | 55,000,000 | 46,000,000 | 36,000,000 | 19,000,000 | 46,000,000 | 30,000,000 | 47,000,000 | 329,000,000 | 121,000,000 | 31,000,000 | 22,000,000 | 28,000,000 | 52,000,000 | 44,000,000 | 193,000,000 | 29,000,000 | 63,000,000 | 37,000,000 | 32,000,000 | 21,000,000 | 58,000,000 | 20,000,000 | 11,000,000 | 14,000,000 | ||||||||||||||||||||||||||||||||||
litigation and investigation costs | 27,000,000 | 30,000,000 | -11,000,000 | 28,000,000 | 17,000,000 | 17,000,000 | 9,000,000 | 5,000,000 | 4,000,000 | 19,000,000 | 14,000,000 | 10,000,000 | 4,000,000 | 20,000,000 | 12,000,000 | 18,000,000 | 20,000,000 | 52,000,000 | 29,000,000 | 22,000,000 | 13,000,000 | 9,000,000 | 2,000,000 | 2,000,000 | 84,000,000 | 18,000,000 | 13,000,000 | 9,000,000 | 13,000,000 | 6,000,000 | 6,000,000 | 2,000,000 | 4,000,000 | 114,000,000 | 173,000,000 | 224,000,000 | 50,000,000 | 14,000,000 | 3,000,000 | 6,000,000 | 4,000,000 | 12,000,000 | 3,000,000 | 28,000,000 | 1,000,000 | 2,000,000 | 0 | 1,000,000 | 2,000,000 | 31,000,000 | 5,000,000 | 8,000,000 | 11,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | 9,000,000 | 1,000,000 | -5,000,000 | 3,000,000 | 47,000,000 | 12,000,000 | |||||||||||||||||||
net gains on sales, consolidation and deconsolidation of facilities | -1,000,000 | -22,000,000 | -10,000,000 | -348,000,000 | -58,000,000 | -2,500,000,000 | -11,000,000 | 1,000,000 | -412,000,000 | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in earnings of unconsolidated affiliates, net of distributions received | 29,000,000 | -21,000,000 | -5,000,000 | -13,000,000 | 5,000,000 | -20,000,000 | -6,000,000 | -6,000,000 | 3,000,000 | -18,000,000 | -2,000,000 | -4,000,000 | 11,000,000 | -12,000,000 | -4,000,000 | -3,000,000 | 21,000,000 | -20,000,000 | 0 | -18,000,000 | 28,000,000 | 10,307,000 | 28,000,000 | -28,000,000 | -11,000,000 | 6,150,000 | -4,000,000 | -5,000,000 | 3,000,000 | -8,844,000 | -1,000,000 | 1,000,000 | 9,000,000 | 4,645,000 | -8,000,000 | -15,000,000 | -8,000,000 | -2,000,000 | 12,000,000 | ||||||||||||||||||||||||||||||||||||||||||
amortization of debt discount and debt issuance costs | 5,000,000 | 5,000,000 | 6,000,000 | 6,000,000 | 6,000,000 | 5,000,000 | 7,000,000 | 6,000,000 | 8,000,000 | 7,000,000 | 7,000,000 | 9,000,000 | 9,000,000 | 10,000,000 | 8,000,000 | 7,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | 9,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 4,000,000 | 10,000,000 | 11,000,000 | 11,000,000 | 11,000,000 | 11,000,000 | 11,000,000 | 8,000,000 | 12,000,000 | 11,000,000 | 10,000,000 | 9,000,000 | 11,000,000 | 14,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 3,000,000 | 4,000,000 | 5,000,000 | 6,000,000 | 5,000,000 | 6,000,000 | 5,000,000 | 7,000,000 | 8,000,000 | 7,000,000 | 8,000,000 | ||||||||||||||||||||||||||
net gains from the sale of investments and long-lived assets | -1,000,000 | -2,000,000 | -2,000,000 | -1,000,000 | -4,000,000 | -10,000,000 | -1,000,000 | -14,000,000 | -2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other items | 2,000,000 | -3,000,000 | -2,000,000 | -3,000,000 | 2,000,000 | -1,000,000 | 0 | 2,000,000 | -5,000,000 | -3,000,000 | 2,000,000 | -1,000,000 | -2,000,000 | 1,000,000 | 71,000,000 | 5,000,000 | -64,000,000 | -10,000,000 | -1,000,000 | -15,000,000 | -7,000,000 | -1,000,000 | -5,000,000 | 2,000,000 | -4,000,000 | -3,000,000 | -7,000,000 | -21,000,000 | 0 | -1,000,000 | 6,000,000 | 13,000,000 | 1,000,000 | 0 | 2,000,000 | 85,000,000 | -1,000,000 | -24,000,000 | -18,000,000 | 0 | 1,000,000 | 0 | 2,000,000 | 9,000,000 | 9,000,000 | -3,000,000 | 5,000,000 | 18,000,000 | -7,000,000 | 8,000,000 | -13,000,000 | -27,000,000 | 7,000,000 | 10,000,000 | 6,000,000 | -4,000,000 | -8,000,000 | -3,000,000 | 9,000,000 | 9,000,000 | 5,000,000 | -6,000,000 | 3,000,000 | 3,000,000 | 0 | 8,000,000 | 1,000,000 | 3,000,000 | 3,000,000 | 4,000,000 | 53,000,000 | ||||||||||
changes in cash from operating assets and liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable | -28,000,000 | -48,000,000 | 28,000,000 | 109,000,000 | -69,000,000 | 62,000,000 | 106,000,000 | 340,000,000 | -263,000,000 | -60,000,000 | 24,000,000 | -28,000,000 | 35,000,000 | -101,000,000 | 35,000,000 | 77,000,000 | -151,000,000 | 5,000,000 | -101,000,000 | -48,000,000 | -53,000,000 | -37,000,000 | 303,000,000 | 14,000,000 | -36,000,000 | 20,000,000 | -158,000,000 | -23,000,000 | 53,000,000 | -66,000,000 | -373,000,000 | -448,000,000 | -431,000,000 | -272,000,000 | -453,000,000 | -508,000,000 | -345,000,000 | -295,000,000 | -484,000,000 | -587,000,000 | -155,000,000 | -192,000,000 | -278,000,000 | -207,000,000 | -160,000,000 | -135,000,000 | -242,000,000 | -148,000,000 | -179,000,000 | -90,000,000 | -229,000,000 | -170,000,000 | -121,000,000 | -117,000,000 | -243,000,000 | ||||||||||||||||||||||||||
inventories and other current assets | 407,000,000 | -15,000,000 | -67,000,000 | 117,000,000 | -108,000,000 | -96,000,000 | -6,000,000 | 34,000,000 | -18,000,000 | -90,000,000 | -209,000,000 | 110,000,000 | 50,000,000 | -153,000,000 | -84,000,000 | -8,000,000 | 181,000,000 | 59,000,000 | -167,000,000 | -74,000,000 | 130,000,000 | -14,000,000 | 21,000,000 | 23,000,000 | -34,000,000 | 51,000,000 | -115,000,000 | -71,000,000 | 185,000,000 | -41,000,000 | -63,000,000 | 12,000,000 | -65,000,000 | -12,000,000 | -18,000,000 | -68,000,000 | -98,000,000 | 110,000,000 | -74,000,000 | -326,000,000 | -66,000,000 | 22,000,000 | 55,000,000 | -113,000,000 | -19,000,000 | 10,000,000 | -11,000,000 | 3,000,000 | 3,000,000 | -9,000,000 | 0 | -16,000,000 | -6,000,000 | -11,000,000 | 14,000,000 | 1,000,000 | -3,000,000 | 10,000,000 | 11,000,000 | 16,000,000 | |||||||||||||||||||||
income taxes | 259,000,000 | -40,000,000 | 5,000,000 | -122,000,000 | 132,000,000 | -805,000,000 | 108,000,000 | -70,000,000 | 783,000,000 | 56,000,000 | -15,000,000 | -107,000,000 | 76,000,000 | 33,000,000 | 27,000,000 | -115,000,000 | 29,000,000 | 1,000,000 | 42,000,000 | 6,000,000 | 19,000,000 | -5,000,000 | 12,000,000 | 2,000,000 | -2,000,000 | -11,000,000 | 9,000,000 | 4,000,000 | -7,000,000 | -45,000,000 | 28,000,000 | 1,000,000 | 8,000,000 | 3,000,000 | 3,000,000 | -18,000,000 | -12,000,000 | -14,000,000 | -37,000,000 | -10,000,000 | 33,000,000 | 17,000,000 | -91,000,000 | -8,000,000 | 17,000,000 | 4,000,000 | 11,000,000 | -3,000,000 | -12,000,000 | -17,000,000 | 9,000,000 | 14,000,000 | -4,000,000 | ||||||||||||||||||||||||||||
accounts payable, accrued expenses and other current liabilities | -145,000,000 | -28,000,000 | 213,000,000 | 0 | 24,000,000 | -153,000,000 | 247,000,000 | -87,000,000 | 337,000,000 | 1,353,000,000 | -144,000,000 | 180,000,000 | -108,000,000 | -109,000,000 | 177,000,000 | -188,000,000 | -183,000,000 | 204,000,000 | -16,000,000 | 71,000,000 | 8,000,000 | -114,000,000 | 29,000,000 | 306,000,000 | -67,000,000 | -200,000,000 | 385,000,000 | 29,000,000 | 20,000,000 | -74,000,000 | -44,000,000 | 62,000,000 | 18,000,000 | -18,000,000 | -146,000,000 | 49,000,000 | 82,000,000 | -2,000,000 | -117,000,000 | 15,000,000 | 45,000,000 | 72,000,000 | -161,000,000 | ||||||||||||||||||||||||||||||||||||||
other long-term liabilities | -41,000,000 | 18,000,000 | 40,000,000 | -8,000,000 | -27,000,000 | -5,000,000 | -1,000,000 | 24,000,000 | 4,000,000 | -2,000,000 | 21,000,000 | -9,000,000 | 13,000,000 | 13,000,000 | -20,000,000 | -21,000,000 | 20,000,000 | 14,000,000 | -12,000,000 | 6,000,000 | 115,000,000 | 141,000,000 | -51,000,000 | -19,000,000 | -33,000,000 | 37,000,000 | -34,000,000 | -49,000,000 | 1,000,000 | -41,000,000 | -8,000,000 | 14,000,000 | 10,000,000 | 24,000,000 | 7,000,000 | -9,000,000 | 12,000,000 | 28,000,000 | 6,000,000 | -9,000,000 | 34,000,000 | 13,000,000 | -22,000,000 | 27,000,000 | -17,000,000 | -6,000,000 | 10,000,000 | 16,000,000 | -19,000,000 | -4,000,000 | 12,000,000 | -35,000,000 | -5,000,000 | 9,000,000 | -27,000,000 | -7,000,000 | 5,000,000 | 1,000,000 | -12,000,000 | -10,000,000 | -1,000,000 | 16,000,000 | 8,000,000 | 6,000,000 | 9,000,000 | 14,000,000 | 17,000,000 | -16,000,000 | 31,000,000 | 9,000,000 | 296,000,000 | ||||||||||
payments for restructuring charges, acquisition-related costs, and litigation costs and settlements | -57,000,000 | -37,000,000 | -3,000,000 | -45,000,000 | -36,000,000 | -34,000,000 | -55,000,000 | -39,000,000 | -25,000,000 | -49,000,000 | -27,000,000 | -54,000,000 | -24,000,000 | -57,000,000 | -59,000,000 | -42,000,000 | -56,000,000 | -37,000,000 | -31,000,000 | -34,000,000 | -51,000,000 | -138,000,000 | -46,000,000 | -68,000,000 | -56,000,000 | -48,000,000 | -32,000,000 | -50,000,000 | -30,000,000 | -33,000,000 | -26,000,000 | -559,000,000 | -33,000,000 | -30,000,000 | -69,000,000 | -43,000,000 | -71,000,000 | -53,000,000 | -33,000,000 | -53,000,000 | |||||||||||||||||||||||||||||||||||||||||
net cash from operating activities | 1,641,000,000 | 731,000,000 | 1,058,000,000 | 936,000,000 | 815,000,000 | -331,000,000 | 1,045,000,000 | 747,000,000 | 586,000,000 | 824,000,000 | 503,000,000 | 598,000,000 | 449,000,000 | 421,000,000 | 315,000,000 | 119,000,000 | 228,000,000 | 357,000,000 | 432,000,000 | 245,000,000 | 534,000,000 | -2,503,798,000 | 593,000,000 | 2,239,000,000 | 129,000,000 | -386,035,000 | 419,000,000 | 284,000,000 | 10,000,000 | -468,532,000 | 338,000,000 | 348,000,000 | 113,000,000 | -406,934,000 | 308,000,000 | -293,000,000 | 269,000,000 | 435,000,000 | 147,000,000 | 191,000,000 | 482,000,000 | 410,000,000 | -57,000,000 | 219,000,000 | 221,000,000 | 255,000,000 | 206,000,000 | 256,000,000 | 136,000,000 | 173,000,000 | 148,000,000 | 178,000,000 | -2,000,000 | 128,000,000 | 191,000,000 | -22,000,000 | 141,000,000 | 120,000,000 | 170,000,000 | -6,000,000 | 67,000,000 | 151,000,000 | 123,000,000 | -133,000,000 | 112,000,000 | 83,000,000 | -15,000,000 | 184,000,000 | 516,000,000 | 123,000,000 | |||||||||||
capital expenditures | -180,000,000 | -364,000,000 | -280,000,000 | -193,000,000 | -173,000,000 | -330,000,000 | -216,000,000 | -145,000,000 | -240,000,000 | -208,000,000 | -176,000,000 | -132,000,000 | -235,000,000 | -290,000,000 | -165,000,000 | -152,000,000 | -155,000,000 | -304,000,000 | -111,000,000 | -122,000,000 | -121,000,000 | 0 | -86,000,000 | -106,000,000 | -182,000,000 | 0 | -156,000,000 | -144,000,000 | -192,000,000 | 0 | -136,000,000 | -125,000,000 | -143,000,000 | 0 | -144,000,000 | -261,000,000 | -201,000,000 | -205,000,000 | -208,000,000 | -276,000,000 | -207,000,000 | -175,000,000 | -184,000,000 | -199,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | -100,000,000 | -82,000,000 | -116,000,000 | -106,000,000 | -70,000,000 | -181,000,000 | -78,000,000 | -53,000,000 | -86,000,000 | 0 | -105,000,000 | -83,000,000 | -160,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||
free cash flows | 1,461,000,000 | 367,000,000 | 778,000,000 | 743,000,000 | 642,000,000 | -661,000,000 | 829,000,000 | 602,000,000 | 346,000,000 | 616,000,000 | 327,000,000 | 466,000,000 | 214,000,000 | 131,000,000 | 150,000,000 | -33,000,000 | 73,000,000 | 53,000,000 | 321,000,000 | 123,000,000 | 413,000,000 | -2,503,798,000 | 507,000,000 | 2,133,000,000 | -53,000,000 | -386,035,000 | 263,000,000 | 140,000,000 | -182,000,000 | -468,532,000 | 202,000,000 | 223,000,000 | -30,000,000 | -406,934,000 | 164,000,000 | -554,000,000 | 68,000,000 | 230,000,000 | -61,000,000 | -85,000,000 | 275,000,000 | 235,000,000 | -241,000,000 | 20,000,000 | 221,000,000 | 255,000,000 | 206,000,000 | 256,000,000 | 136,000,000 | 173,000,000 | 48,000,000 | 96,000,000 | -118,000,000 | 22,000,000 | 121,000,000 | -40,000,000 | 42,000,000 | 117,000,000 | -92,000,000 | 67,000,000 | 46,000,000 | 40,000,000 | -293,000,000 | 112,000,000 | 83,000,000 | -15,000,000 | 184,000,000 | 516,000,000 | 123,000,000 | ||||||||||||
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment | -180,000,000 | -364,000,000 | -280,000,000 | -193,000,000 | -173,000,000 | -330,000,000 | -216,000,000 | -145,000,000 | -240,000,000 | -208,000,000 | -176,000,000 | -132,000,000 | -235,000,000 | -290,000,000 | -165,000,000 | -152,000,000 | -155,000,000 | -304,000,000 | -111,000,000 | -122,000,000 | -121,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of businesses or joint venture interests, net of cash acquired | -121,000,000 | -42,000,000 | -119,000,000 | -120,000,000 | -27,000,000 | -47,000,000 | -14,000,000 | -61,000,000 | -449,000,000 | -114,000,000 | -14,000,000 | -48,000,000 | -48,000,000 | -10,000,000 | -158,000,000 | -26,000,000 | -40,000,000 | -1,156,000,000 | 0 | -39,000,000 | -25,000,000 | -5,000,000 | -1,000,000 | -55,000,000 | -10,000,000 | -11,000,000 | -2,000,000 | -8,000,000 | -73,000,000 | -16,000,000 | -15,000,000 | -21,000,000 | -2,000,000 | -65,000,000 | -29,000,000 | -220,000,000 | -84,000,000 | -625,000,000 | -11,000,000 | -243,000,000 | |||||||||||||||||||||||||||||||||||||||||
proceeds from sales of facilities and other assets | 2,000,000 | 20,000,000 | 4,000,000 | 3,000,000 | 11,000,000 | 16,000,000 | 917,000,000 | 18,000,000 | 4,030,000,000 | 33,000,000 | 22,000,000 | 3,000,000 | 13,000,000 | 1,000,000 | 0 | 61,000,000 | 148,000,000 | 1,111,000,000 | 111,000,000 | 13,000,000 | 17,000,000 | 56,000,000 | 425,000,000 | 752,000,000 | 0 | 0 | 0 | 573,000,000 | 521,000,000 | 105,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of marketable securities and long-term investments | 22,000,000 | 19,000,000 | 37,000,000 | 23,000,000 | 14,000,000 | 38,000,000 | 8,000,000 | 10,000,000 | 7,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of marketable securities and long-term investments | -26,000,000 | -21,000,000 | -31,000,000 | -21,000,000 | -17,000,000 | -48,000,000 | -20,000,000 | -16,000,000 | -10,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities | -317,000,000 | -389,000,000 | -385,000,000 | -314,000,000 | -187,000,000 | -372,000,000 | 667,000,000 | -194,000,000 | 3,328,000,000 | -333,000,000 | -169,000,000 | -181,000,000 | -286,000,000 | -306,000,000 | -302,000,000 | -140,000,000 | -60,000,000 | -1,516,000,000 | 997,000,000 | -50,000,000 | -145,000,000 | 196,808,000 | -117,000,000 | -85,000,000 | -204,000,000 | 392,582,000 | -123,000,000 | -164,000,000 | -139,000,000 | -182,230,000 | -105,000,000 | -148,000,000 | 373,000,000 | -256,946,000 | 535,000,000 | -280,000,000 | -204,000,000 | -266,000,000 | 320,000,000 | -45,000,000 | -287,000,000 | -798,000,000 | -187,000,000 | -408,000,000 | -93,000,000 | -102,000,000 | -129,000,000 | -145,000,000 | -58,000,000 | -68,000,000 | -180,000,000 | -95,000,000 | -24,000,000 | 174,000,000 | -71,000,000 | 8,000,000 | -50,000,000 | -161,000,000 | |||||||||||||||||||||||
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of borrowings | -33,000,000 | -2,282,000,000 | -28,000,000 | -30,000,000 | -32,000,000 | -31,000,000 | -33,000,000 | -38,000,000 | -2,141,000,000 | -64,000,000 | -41,000,000 | -1,392,000,000 | -45,000,000 | -42,000,000 | -1,865,000,000 | -879,000,000 | -2,000,000 | -1,000,000 | -1,000,000 | 0 | -874,000,000 | -5,000,000 | -7,000,000 | -6,000,000 | -384,000,000 | -900,000,000 | -1,000,000 | 0 | 0 | 0 | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from borrowings | 14,000,000 | 2,255,000,000 | 6,000,000 | 14,000,000 | 1,000,000 | 7,000,000 | 8,000,000 | 6,000,000 | 2,000,000 | 2,000,000 | 6,000,000 | 1,350,000,000 | 12,000,000 | 7,000,000 | 2,011,000,000 | 2,000,000 | 0 | 600,000,000 | 0 | 1,000,000 | 0 | 0 | 1,332,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchases of common stock | -318,000,000 | -198,000,000 | -93,000,000 | -747,000,000 | -348,000,000 | 0 | -124,000,000 | -270,000,000 | -278,000,000 | -110,000,000 | 0 | -40,000,000 | -50,000,000 | -124,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distributions paid to noncontrolling interests | -197,000,000 | -224,000,000 | -211,000,000 | -185,000,000 | -189,000,000 | -185,000,000 | -173,000,000 | -161,000,000 | -162,000,000 | -169,000,000 | -155,000,000 | -136,000,000 | -134,000,000 | -128,000,000 | -122,000,000 | -175,000,000 | -135,000,000 | -107,000,000 | -104,000,000 | -93,000,000 | -119,000,000 | -84,000,000 | -24,000,000 | -76,000,000 | -79,000,000 | -70,000,000 | -74,000,000 | -77,000,000 | -76,000,000 | -64,000,000 | -55,000,000 | -67,000,000 | -56,000,000 | -51,000,000 | -44,000,000 | -45,000,000 | -42,000,000 | -12,000,000 | -11,000,000 | -15,000,000 | -4,000,000 | -2,000,000 | -2,000,000 | -2,000,000 | -3,000,000 | -2,000,000 | -1,000,000 | -2,000,000 | -2,000,000 | ||||||||||||||||||||||||||||||||
proceeds from the sale of noncontrolling interests | 6,000,000 | 15,000,000 | 9,000,000 | 7,000,000 | 11,000,000 | 10,000,000 | 3,000,000 | 5,000,000 | 5,000,000 | 6,000,000 | 7,000,000 | 5,000,000 | 25,000,000 | 7,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of noncontrolling interests | -549,000,000 | -4,000,000 | -9,000,000 | -38,000,000 | -41,000,000 | -73,000,000 | -39,000,000 | -36,000,000 | -52,000,000 | -40,000,000 | -48,000,000 | -38,000,000 | -41,000,000 | -39,000,000 | -32,000,000 | -15,000,000 | -14,000,000 | -8,000,000 | -14,000,000 | -3,000,000 | -2,000,000 | 30,133,000 | -4,792,000 | -2,000,000 | -3,000,000 | -3,000,000 | 634,785,000 | -1,000,000 | -633,000,000 | -9,000,000 | 716,553,000 | -717,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
repayments of advances from managed care payers | 1,000,000 | -21,000,000 | -1,000,000 | -11,000,000 | -150,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
taxes paid related to net share settlement, net of proceeds from shares issued under stock-based compensation plans | -86,000,000 | -4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities | -1,240,000,000 | -434,000,000 | -323,000,000 | -996,000,000 | -648,000,000 | -372,000,000 | -498,000,000 | -154,000,000 | -2,661,000,000 | -317,000,000 | -214,000,000 | -249,000,000 | -255,000,000 | -465,000,000 | -156,000,000 | -33,000,000 | -1,127,000,000 | 1,231,000,000 | -1,331,000,000 | -142,000,000 | -694,000,000 | -701,819,000 | -690,000,000 | 747,000,000 | 426,000,000 | 81,976,000 | -231,000,000 | -123,000,000 | -30,000,000 | 758,698,000 | -136,000,000 | -771,000,000 | -123,000,000 | 956,235,000 | -889,000,000 | 640,000,000 | -72,000,000 | -241,000,000 | -95,000,000 | -240,000,000 | -44,000,000 | 502,000,000 | 236,000,000 | 182,000,000 | -89,000,000 | 284,000,000 | 338,000,000 | -153,000,000 | 169,000,000 | -134,000,000 | -79,000,000 | -7,000,000 | -19,000,000 | -296,000,000 | -11,000,000 | -11,000,000 | -2,000,000 | -52,000,000 | -40,000,000 | -23,000,000 | -1,000,000 | 1,000,000 | 0 | 1,000,000 | 1,000,000 | -2,000,000 | 1,000,000 | 349,000,000 | 1,000,000 | ||||||||||||
net increase in cash and cash equivalents | 84,000,000 | -92,000,000 | 350,000,000 | -374,000,000 | -20,000,000 | -1,075,000,000 | 1,214,000,000 | 399,000,000 | 1,253,000,000 | 174,000,000 | 120,000,000 | 72,000,000 | 98,000,000 | 53,000,000 | -305,000,000 | -214,000,000 | 2,901,000,000 | 351,000,000 | -159,000,000 | 363,000,000 | -46,000,000 | 67,000,000 | -7,000,000 | -72,000,000 | 372,000,000 | -94,000,000 | 151,000,000 | -7,000,000 | -206,000,000 | 265,000,000 | 28,000,000 | 7,000,000 | -313,000,000 | 122,000,000 | -101,000,000 | -41,000,000 | -27,000,000 | 106,000,000 | 145,000,000 | -114,000,000 | 97,000,000 | 843,000,000 | 130,000,000 | 80,000,000 | |||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | 2,883,000,000 | 0 | 0 | 0 | 3,019,000,000 | 0 | 0 | 0 | 1,228,000,000 | 0 | 0 | 0 | 858,000,000 | 0 | 0 | 0 | 2,364,000,000 | 0 | 0 | 0 | 2,446,000,000 | 0 | 0 | 262,000,000 | 0 | 0 | 411,000,000 | 0 | 0 | 611,000,000 | 0 | 0 | 0 | 0 | 356,000,000 | 0 | 0 | 0 | 193,000,000 | 0 | 0 | 0 | 113,000,000 | 0 | 0 | 0 | 364,000,000 | 0 | 0 | 0 | 113,000,000 | 0 | 0 | 0 | 405,000,000 | 0 | 0 | 0 | 690,000,000 | 0 | 0 | 0 | 507,000,000 | 0 | 0 | 0 | 572,000,000 | 0 | 0 | 0 | 784,000,000 | 1,373,000,000 | 0 | 0 | 654,000,000 | 0 | 38,000,000 | ||||
cash and cash equivalents at end of period | 2,967,000,000 | -92,000,000 | 350,000,000 | -374,000,000 | 2,999,000,000 | -1,075,000,000 | 1,214,000,000 | 399,000,000 | 2,481,000,000 | 174,000,000 | 120,000,000 | 168,000,000 | 766,000,000 | -350,000,000 | -143,000,000 | -54,000,000 | 1,405,000,000 | 72,000,000 | 98,000,000 | 53,000,000 | 2,141,000,000 | -214,000,000 | 2,901,000,000 | 613,000,000 | 65,000,000 | -3,000,000 | 252,000,000 | 97,000,000 | -571,000,000 | 974,000,000 | -46,000,000 | 67,000,000 | -7,000,000 | -72,000,000 | 728,000,000 | -94,000,000 | 151,000,000 | 114,000,000 | 185,000,000 | -7,000,000 | -206,000,000 | 265,000,000 | 141,000,000 | 31,000,000 | -8,000,000 | -5,000,000 | 95,000,000 | 281,000,000 | 1,000,000 | -22,000,000 | 104,000,000 | -72,000,000 | -79,000,000 | -3,000,000 | 267,000,000 | 7,000,000 | -313,000,000 | 122,000,000 | 589,000,000 | -41,000,000 | -27,000,000 | 106,000,000 | 652,000,000 | -5,000,000 | 160,000,000 | 74,000,000 | 278,000,000 | -83,000,000 | -20,000,000 | 91,000,000 | 584,000,000 | 975,000,000 | -114,000,000 | 97,000,000 | 1,497,000,000 | 130,000,000 | 118,000,000 | ||||
supplemental disclosures: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest paid, net of capitalized interest | -24,000,000 | -366,000,000 | -100,000,000 | -300,000,000 | -99,000,000 | -296,000,000 | -96,000,000 | -297,000,000 | -162,000,000 | -293,000,000 | -144,000,000 | -268,000,000 | -177,000,000 | -247,000,000 | -185,000,000 | -250,000,000 | -166,000,000 | -273,000,000 | -178,000,000 | -296,000,000 | -190,000,000 | -292,000,000 | -293,000,000 | -172,000,000 | -221,000,000 | -326,000,000 | -158,000,000 | -151,000,000 | -332,000,000 | -169,000,000 | -149,000,000 | -336,000,000 | -129,000,000 | -335,000,000 | -132,000,000 | -340,000,000 | -134,000,000 | -268,000,000 | -117,000,000 | -239,000,000 | -127,000,000 | -255,000,000 | -105,000,000 | -131,000,000 | -69,000,000 | -101,000,000 | -125,000,000 | -88,000,000 | -107,000,000 | -79,000,000 | -102,000,000 | -92,000,000 | -73,000,000 | -85,000,000 | -97,000,000 | -89,000,000 | -112,000,000 | -89,000,000 | -112,000,000 | -99,000,000 | -100,000,000 | -91,000,000 | -149,000,000 | -70,000,000 | -126,000,000 | -70,000,000 | -125,000,000 | -81,000,000 | -123,000,000 | -67,000,000 | -124,000,000 | -123,000,000 | -131,000,000 | -67,000,000 | -94,000,000 | ||||||
income tax payments | -8,000,000 | -121,000,000 | -87,000,000 | -235,000,000 | -7,000,000 | -963,000,000 | -68,000,000 | -235,000,000 | -5,000,000 | -31,000,000 | -54,000,000 | -13,000,000 | -8,000,000 | -132,000,000 | -8,000,000 | -38,000,000 | -20,000,000 | -32,000,000 | -2,000,000 | -5,000,000 | -5,000,000 | -3,000,000 | -10,000,000 | 0 | -4,000,000 | -1,000,000 | 3,000,000 | -2,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net losses on sales, consolidation and deconsolidation of facilities | -13,000,000 | 1,000,000 | -1,000,000 | -1,000,000 | -2,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss from early extinguishment of debt | 0 | 0 | 0 | 8,000,000 | 0 | 0 | 0 | 0 | 66,000,000 | 43,000,000 | 0 | 20,000,000 | 31,000,000 | 23,000,000 | 312,000,000 | 180,000,000 | 0 | 47,000,000 | 0 | 1,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
debt issuance costs | 0 | -1,000,000 | 0 | 0 | -21,000,000 | -3,000,000 | -16,000,000 | 0 | -26,000,000 | -21,000,000 | -1,000,000 | -45,000,000 | 0 | -18,000,000 | -33,000,000 | -4,000,000 | -4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
advances from managed care payers | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable, accrued expenses, contract liabilities and other current liabilities | 19,000,000 | 253,000,000 | 130,000,000 | 62,000,000 | -230,000,000 | 44,000,000 | -178,000,000 | -404,000,000 | -360,000,000 | -435,000,000 | 83,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pre-tax loss from discontinued operations | 0 | 1,000,000 | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities from discontinued operations, excluding income taxes | 0 | 1,000,000 | -3,000,000 | -2,000,000 | -1,000,000 | -2,000,000 | -1,000,000 | -1,000,000 | -3,000,000 | -7,000,000 | -22,000,000 | -6,000,000 | -13,000,000 | -7,000,000 | 3,000,000 | 2,000,000 | 9,000,000 | 3,000,000 | -28,000,000 | 56,000,000 | 34,000,000 | -6,000,000 | -8,000,000 | 17,000,000 | -24,000,000 | 32,000,000 | 45,000,000 | -42,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of marketable securities and equity investments | -50,000,000 | -17,000,000 | -19,000,000 | -18,000,000 | -24,000,000 | -27,000,000 | -22,000,000 | -19,000,000 | -85,000,000 | -4,000,000 | -8,000,000 | -11,000,000 | -31,000,000 | -6,000,000 | -4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
medicare advances and grants received by unconsolidated affiliates, net of recoupment | -59,000,000 | -14,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pre-tax income from discontinued operations | -1,000,000 | -1,000,000 | -2,000,000 | -10,000,000 | 0 | 8,000,000 | -3,000,000 | 2,000,000 | 3,000,000 | 22,000,000 | 18,000,000 | 23,000,000 | 148,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of marketable securities, long-term investments and other assets | 14,000,000 | 17,000,000 | 9,000,000 | 15,000,000 | 52,000,000 | 3,000,000 | 6,000,000 | 13,000,000 | 0 | 12,000,000 | 6,000,000 | 9,000,000 | 25,000,000 | 10,000,000 | 43,000,000 | 5,000,000 | 4,000,000 | 22,000,000 | 9,000,000 | 134,000,000 | 4,000,000 | 26,000,000 | 12,000,000 | 12,000,000 | 12,000,000 | 42,000,000 | 9,000,000 | 3,000,000 | 6,000,000 | 29,000,000 | -1,000,000 | 0 | 3,000,000 | 9,000,000 | 3,000,000 | 0 | 3,000,000 | 8,000,000 | 4,000,000 | 2,000,000 | 3,000,000 | 28,000,000 | 21,000,000 | 5,000,000 | 5,000,000 | 53,000,000 | 15,000,000 | 4,000,000 | 12,000,000 | 12,000,000 | 6,000,000 | 31,000,000 | 18,000,000 | 32,000,000 | 178,000,000 | 4,000,000 | 10,000,000 | 205,000,000 | |||||||||||||||||||||||
net decrease in cash and cash equivalents | -92,000,000 | -143,000,000 | -54,000,000 | -959,000,000 | 65,000,000 | 97,000,000 | -138,000,000 | -5,000,000 | 160,000,000 | 74,000,000 | -294,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of borrowings under credit facility | 0 | -500,000,000 | -240,000,000 | -785,000,000 | -600,000,000 | -495,000,000 | -145,000,000 | -750,000,000 | -700,000,000 | 0 | -200,000,000 | -995,000,000 | -935,000,000 | -565,000,000 | -625,000,000 | -690,000,000 | -465,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from borrowings under credit facility | 0 | 0 | 740,000,000 | 870,000,000 | 600,000,000 | 685,000,000 | 145,000,000 | 750,000,000 | 700,000,000 | 0 | 200,000,000 | 995,000,000 | 825,000,000 | 575,000,000 | 375,000,000 | 820,000,000 | 685,000,000 | 665,000,000 | 465,000,000 | 430,000,000 | 140,000,000 | 460,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of other borrowings | -38,000,000 | -1,171,000,000 | -1,471,000,000 | -541,000,000 | -3,015,000,000 | -181,000,000 | -48,000,000 | -4,416,000,000 | -48,000,000 | -1,620,000,000 | -77,000,000 | -70,000,000 | -91,000,000 | -3,070,000,000 | -42,000,000 | -36,000,000 | -38,000,000 | -38,000,000 | -38,000,000 | -19,000,000 | -1,960,000,000 | -32,000,000 | -28,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from other borrowings | 1,459,000,000 | 4,000,000 | 1,405,000,000 | 4,000,000 | 2,503,000,000 | 1,305,000,000 | 7,000,000 | 4,202,000,000 | 9,000,000 | 1,507,000,000 | 1,000,000 | 7,000,000 | 7,000,000 | 2,951,000,000 | 756,000,000 | 1,000,000 | -50,000,000 | 21,000,000 | 2,786,000,000 | 401,000,000 | 0 | 500,000,000 | 508,000,000 | 600,000,000 | 4,600,000,000 | 0 | 1,057,000,000 | 850,000,000 | 800,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of noncontrolling interests | 4,000,000 | 11,000,000 | 2,000,000 | 6,000,000 | 6,000,000 | 2,000,000 | 3,000,000 | 2,000,000 | 3,000,000 | 4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of facilities and other assets — continuing operations | 1,000,000 | 1,000,000 | 11,000,000 | 4,000,000 | -1,000,000 | 41,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of facilities and other assets — discontinued operations | 0 | 0 | 17,000,000 | 2,000,000 | 5,000,000 | 10,000,000 | 0 | 35,000,000 | 1,000,000 | 0 | 0 | -30,000,000 | 251,000,000 | 77,000,000 | 60,000,000 | 23,000,000 | 8,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from shares issued under stock-based compensation plans, net of taxes paid relatedto net share settlement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of stock options and employee stock purchase plan | 2,000,000 | 7,000,000 | 8,000,000 | 3,000,000 | 2,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 1,000,000 | 5,000,000 | 9,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other long-term assets | -8,000,000 | -2,000,000 | 5,000,000 | -2,000,000 | -2,000,000 | 2,000,000 | -4,000,000 | 7,000,000 | -4,000,000 | -10,000,000 | 2,000,000 | -3,000,000 | 5,000,000 | -23,000,000 | 29,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
medicare advances and grants received by unconsolidated affiliates | 19,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for doubtful accounts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt issue costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
noncash lease expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of effects from purchases of new businesses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in patient receivables | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in supplies, prepaid, and other assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in contract liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in accounts payable, accrued expenses, and other liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of new businesses and equity interests, net of cash received | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale of property and equipment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in deposits and notes receivables | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other investing activities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in funds due from united surgical partners, inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from debt obligations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments on debt obligations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distributions to noncontrolling interest owners | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sales of noncontrolling interests | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contribution from members | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distributions to members | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in cash and restricted cash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and restricted cash, beginning of period | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and restricted cash, end of period | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental information: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for income taxes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
noncash transactions: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets acquired under finance lease obligations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in accounts payable due to property and equipment received but not paid | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tyler acquisition | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
right of use assets acquired under operating leases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment — continuing operations | -86,000,000 | -106,000,000 | -182,000,000 | -156,000,000 | -144,000,000 | -192,000,000 | -136,000,000 | -125,000,000 | -143,000,000 | -144,000,000 | -261,000,000 | -201,000,000 | -205,000,000 | -208,000,000 | -276,000,000 | -207,000,000 | -175,000,000 | -184,000,000 | -199,000,000 | -100,000,000 | -82,000,000 | -116,000,000 | -106,000,000 | -70,000,000 | -78,000,000 | -181,000,000 | -78,000,000 | -53,000,000 | -85,000,000 | -99,000,000 | -74,000,000 | -159,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
income tax (payments) refunds | -3,000,000 | -4,000,000 | 2,000,000 | -24,000,000 | -1,000,000 | 0 | -4,000,000 | 1,000,000 | -6,000,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in patient receivables | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of new businesses and equity interests, net of cash received of 0, 925, and 0 for 2019, 2018 and 2017, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
change in deposits and notes receivables | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
change in funds due from united surgical partners, inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets acquired under capital leases | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
centennial acquisition | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
reconciliation of cash and restricted cash: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash at beginning of period | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash at beginning of period | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and restricted cash at beginning of period | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash at end of period | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash at end of period | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and restricted cash at end of period | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of equity investments | -5,000,000 | -8,000,000 | -1,000,000 | -6,000,000 | -7,000,000 | -30,000,000 | -62,000,000 | -2,000,000 | -2,000,000 | -17,000,000 | -18,000,000 | -116,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of noncontrolling interests | 6,000,000 | 5,000,000 | 4,000,000 | 7,000,000 | 2,000,000 | 5,000,000 | 15,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax refunds | 9,000,000 | -11,000,000 | 0 | 17,000,000 | 17,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on fixed asset impairment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in supplies, prepaids, and other assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of new businesses and equity interests, net of cash received of 925, 0 and 394 for 2018, 2017 and 2016, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in cash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, beginning of period | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, end of period | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sunnyvale acquisition | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash borrowed | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash from purchases of equipment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash from payments on debt obligations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gains on sales, consolidation and deconsolidation of facilities | -110,000,000 | -104,000,000 | 0 | -3,000,000 | -1,000,000 | -147,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax refunds (payments) | 1,000,000 | 1,000,000 | -1,000,000 | 3,000,000 | -7,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of new businesses and equity interests, net of cash received of 0 and 135 for 2017 and 2016, respectively | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from doubtful accounts | 355,000,000 | 354,000,000 | 367,000,000 | 352,000,000 | 376,000,000 | 391,000,000 | 371,000,000 | 352,000,000 | 363,000,000 | 356,000,000 | 249,000,000 | 320,000,000 | 380,000,000 | 348,000,000 | 210,000,000 | 207,000,000 | 207,000,000 | 200,000,000 | 206,000,000 | 186,000,000 | 193,000,000 | 184,000,000 | 193,000,000 | 171,000,000 | 182,000,000 | 191,000,000 | 187,000,000 | 173,000,000 | 189,000,000 | 181,000,000 | 193,000,000 | 167,000,000 | 156,000,000 | 166,000,000 | 164,000,000 | 153,000,000 | 149,000,000 | 134,000,000 | 141,000,000 | 151,000,000 | 141,000,000 | 138,000,000 | 206,000,000 | 153,000,000 | 158,000,000 | 228,000,000 | 872,000,000 | ||||||||||||||||||||||||||||||||||
income from early extinguishment of debt | 138,000,000 | 0 | 0 | 0 | 171,000,000 | 177,000,000 | 0 | 0 | 15,000,000 | 0 | 4,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from employee stock plan purchases | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pre-tax (income) income from discontinued operations | 3,000,000 | 15,000,000 | -6,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of noncontrolling interests | -6,000,000 | -3,000,000 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of stock options | 0 | 1,000,000 | 0 | 6,000,000 | 2,000,000 | 7,000,000 | 3,000,000 | 12,000,000 | 5,000,000 | 6,000,000 | 0 | 1,000,000 | 6,000,000 | 15,000,000 | 2,000,000 | 1,000,000 | 8,000,000 | 42,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pre-tax loss (income) from discontinued operations | 2,000,000 | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contributions from noncontrolling interests | 1,000,000 | 0 | 1,000,000 | 2,000,000 | 3,000,000 | 2,000,000 | 0 | 13,000,000 | 1,000,000 | 0 | 0 | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
undistributed earnings from affiliates | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax benefit | 17,000,000 | -21,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred debt issuance costs | -1,000,000 | -12,000,000 | 1,000,000 | -1,000,000 | -24,000,000 | -22,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of noncontrolling interest | -254,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment — discontinued operations | 0 | 0 | 0 | -1,000,000 | -6,000,000 | -9,000,000 | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchases of preferred stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash dividends on preferred stock | -6,000,000 | -6,000,000 | -6,000,000 | -6,000,000 | -6,000,000 | -6,000,000 | -6,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pre-tax gain from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from interest rate swap agreement | 21,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of businesses or joint venture interests | -14,000,000 | -24,000,000 | -18,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from borrowing under credit facility | 558,000,000 | 433,000,000 | 220,000,000 | 658,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets and goodwill, and restructuring charges | 7,000,000 | 6,000,000 | 3,000,000 | 3,000,000 | 9,000,000 | 8,000,000 | 2,000,000 | 8,000,000 | 3,000,000 | 7,000,000 | 1,000,000 | 5,000,000 | 1,000,000 | 2,000,000 | 1,000,000 | 3,000,000 | 9,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
fair market value adjustments related to interest rate swap and libor cap agreements | -2,000,000 | 19,000,000 | 0 | 0 | 0 | -4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments against reserves for restructuring charges and litigation costs and settlements | -21,000,000 | -23,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
construction of new and replacement hospitals | 0 | -1,000,000 | -7,000,000 | -5,000,000 | -11,000,000 | -13,000,000 | -18,000,000 | -16,000,000 | -10,000,000 | -9,000,000 | -27,000,000 | -29,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
release of escrow funds | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain on sales of investments | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain from early extinguishment of debt | 21,000,000 | -134,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of marketable securities | 0 | -11,000,000 | -9,000,000 | -9,000,000 | -1,000,000 | -7,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distributions received from investments in reserve yield plus fund | 0 | 0 | 8,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from hospital authority bonds | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of mandatory convertible preferred stock | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments against reserves for restructuring charges and litigation costs | -6,000,000 | -14,000,000 | -7,000,000 | -25,000,000 | -27,000,000 | -24,000,000 | -109,000,000 | -28,000,000 | -28,000,000 | -27,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of property and equipment — discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries | 36,000,000 | 11,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
litigation and investigation costs, net of insurance recoveries | 18,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(gain) income from early extinguishment of debt | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt discount and issue costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pre-tax (gain) income from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities cash flows from investing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment—continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment—discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of business or joint venture interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of facilities and other assets—discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distributions received from (reclassification of) investments in reserve yield plus fund | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from cash surrender value or basis reduction of insurance policies | 7,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities cash flows from financing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of businesses or joint venture interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of business or joint venture interest | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
fair market value adjustments related to libor cap agreement | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gain from early extinguishment of debt | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pretax income from discontinued operations | -9,000,000 | 3,000,000 | 20,000,000 | 9,000,000 | 10,000,000 | -16,000,000 | 19,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
insurance recoveries for property damage | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of business | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
dividends paid to noncontrolling interests | -2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net gains on sales of investments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pretax (income) income from discontinued operations | -8,000,000 | 38,000,000 | -1,000,000 | 31,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cumulative effect of change in accounting principle | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
insurance recoveries for business interruption and other costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities from discontinued operations, excluding income taxes and insurance recoveries for business interruption and other costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
reclassification of investments in reserve yield plus fund out of cash equivalents | 34,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
release of restricted cash related to letter of credit facility | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cumulative effect of changes in accounting principle | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of marketable securities, long-term investments and other assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale of new senior notes | 0 | 0 | 773,000,000 | 0 | 1,374,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchases of senior notes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation charges | 10,000,000 | 10,000,000 | 11,000,000 | 11,000,000 | 12,000,000 | 13,000,000 | 13,000,000 | 25,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increases (decreases) in cash from changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
construction of new hospitals. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from cash surrender value of insurance policies | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of facilities — discontinued operations | 9,000,000 | 38,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
costs of litigation and investigations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of long-term investments and other assets | 174,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax payments made | -2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increases (decreases) in cash from changes in operating assets and liabilities, net of effects from sales of facilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of property and buyout of discontinued operation joint venture interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of facilities, investments and other assets | 26,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments of borrowings | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax refunds received (payments made) | -3,000,000 | -6,000,000 | -2,000,000 | 537,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets and restructuring charges | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increases (decreases) in cash from changes in operating assets and liabilities, net of effects from purchases of new businesses and sales of facilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes payable | 4,000,000 | 541,000,000 | 73,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gulf coast operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
insurance recoveries | 10,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment and restructuring charges | 205,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
construction of new hospitals | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deposits on purchases of property and equipment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash released from escrow accounts to fund construction costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of facilities, long-term investments and other assets | 36,000,000 | 46,000,000 | 71,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in hospital authority bonds | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other items, including expenditures related to prior-year purchases of new businesses | 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income taxes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets, goodwill and investment securities, and restructuring charges | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in cash from changes in operating assets and liabilities, net of effects from purchases and sales of businesses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash released from escrow accounts to fund construction costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments of other borrowings | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest paid | 46,000,000 | 194,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes paid, net of refunds received | 0 | 521,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash released from escrow account to fund construction costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit related to stock option exercises | 38,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations impairment charge | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other items, including, in 2003, settlements of litigation and investigations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchases of senior, senior subordinated and exchangeable subordinated notes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment, restructuring and other unusual charges | 462,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increases (decreases) in cash from changes in operating assets and liabilities, net of effects from purchases of businesses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net expenditures for discontinued operations and other unusual charges | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided by operating activities | 1,269,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of businesses, net of cash acquired | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash used in investing activities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of treasury stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash used in financing activities |